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Abstract:
This review will discuss in detail the pathophysiology of asthma from the 
point of view of lung mechanics.  In particular, we will explain how 
asthma is more than just airflow limitation resulting from airway 
narrowing, but in fact involves multiple consequences of airway 
narrowing, including ventilation heterogeneity, airway closure, and 
airway hyperresponsiveness.  In addition, the relationship between the 
airway and surrounding lung parenchyma is thought to be critically 
important in asthma, especially as related to the response to deep 
inhalation.  Furthermore, dynamic changes in lung mechanics over time 
may yield important information about asthma stability, as well as 
potentially provide a window into future disease control.  All of these 
features of mechanical properties of the lung in asthma will be explained 
by providing evidence from multiple investigative methods, including not 
only traditional pulmonary function testing, but also more sophisticated 
techniques such as forced oscillation, multiple breath nitrogen washout, 
and different imaging modalities.  Throughout the paper we will link the 
lung mechanical features of asthma to clinical manifestations of asthma 
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Abstract:  This review will discuss in detail the pathophysiology of asthma from the point of 
view of lung mechanics.  In particular, we will explain how asthma is more than just airflow 
limitation resulting from airway narrowing, but in fact involves multiple consequences of airway 
narrowing, including ventilation heterogeneity, airway closure, and airway hyperresponsiveness.  
In addition, the relationship between the airway and surrounding lung parenchyma is thought to 
be critically important in asthma, especially as related to the response to deep inhalation.  
Furthermore, dynamic changes in lung mechanics over time may yield important information 
about asthma stability, as well as potentially provide a window into future disease control.  All of 
these features of mechanical properties of the lung in asthma will be explained by providing 
evidence from multiple investigative methods, including not only traditional pulmonary function 
testing, but also more sophisticated techniques such as forced oscillation, multiple breath 
nitrogen washout, and different imaging modalities.  Throughout the paper we will link the lung 




 The pathophysiology of asthma involves much more than just airway narrowing as seen 
by airflow obstruction on spirometry.
 The consequences of airway narrowing include increased airway resistance, airtrapping, 
dynamic hyperinflation, ventilation heterogeneity, airway closure and airways 
hyperresponsiveness































































 Airway-parenchymal interdependence plays an important role in determining lung 
mechanics in asthma.  In particular, interdependence influences airway smooth muscle 
constriction and the response of the lung to deep inhalation.
 Changes in the physical properties of the lung parenchyma are also involved in the 
pathophysiology of asthma, and include changes in lung structure and surfactant that may 
result in altered lung compliance.
 Multiple modalities may be used to detect changes in lung mechanics in asthma, 
including spirometry, changes in lung volumes, forced oscillation technique, single and 
multiple breath nitrogen washout, and various techniques of lung imaging such as CT, 
SPECT, PET, and He3-MRI.
 The clinical manifestations of asthma reflect multiple aspects of altered lung mechanics.
































































Asthma is a complex lung disease that traditionally has been defined as variable and excessive 
narrowing of the airways in response to a variety of stimuli, which leads to airflow limitation and 
the clinical manifestations of cough, wheezing, shortness of breath and chest tightness.  
Symptoms are highly variable in their expression, occurring at rest, or only upon exposure to an 
irritant or other trigger, like air pollution, allergen, upper respiratory infection, or exercise.  
Comorbidities also contribute to the severity and control of symptoms, such as obesity, 
gastroesophageal reflux disease (GERD), rhinosinusitis, and emotional stress.  The diagnosis is 
made by demonstrating periodic airflow limitation by spirometry, or airflow limitation that is 
alleviated by bronchodilator, in the context of the clinical presentation.  Airway 
hyperresponsiveness (AHR) may also be demonstrated by direct or indirect bronchial challenge 
testing in order to confirm a diagnosis.  
However, asthma involves much more than simple airway narrowing.  Indeed, over the past few 
decades, multiple observations and experiments have revealed the complexity of lung 
mechanical abnormalities that occur in asthma, which culminate in airway narrowing and AHR, 
the hallmarks of asthma [12, 228].  Among these are the behavior of airway smooth muscle, the 
importance of interdependence between lung parenchyma and airways, the effects of deep 
inflation, the role of ventilation heterogeneity and airway closure, and mechanical changes in the 
lung parenchyma.  These abnormalities of lung function in asthma are thought to contribute to 
the clinical expression of the disease related to asthma severity and control.  In this review, we 































































will provide detailed descriptions of these various abnormalities of lung mechanics in asthma, 
and relate them to how they are expressed clinically in patients with asthma.  
The Pathology of Asthma
Traditionally asthma has been considered a disease of airway inflammation.  The old dichotomy 
of intrinsic vs. extrinsic asthma, which was thought to relate to non-allergic vs. allergic asthma, 
respectively, has been replaced with a number of different endotypes and phenotypes that reflect 
the underlying pathology and clinical expression of the disease [201].  A more contemporary 
view has been that asthma is driven by eosinophilic or non-eosinophilic inflammation, with the 
former categorized as under the control of T-helper type II cell regulation (TH2) [54, 195]. 
(Figure 1).  In particular, upon exposure to allergens, TH2 cells promote the release of cytokines 
such as IL-4, IL-5 and IL-13 that result in eosinophil recruitment and activation in the airways, 
elaboration of IgE and activation of mast cells, and stimulation of airway smooth muscle and 
mucus glands.  In addition, upon exposure to viruses and airway irritants, non-allergic TH2 
stimulation may lead to IL-5 and IL-13 release from innate lymphoid type 2 cells and resultant 
eosinophilic inflammation.  In contrast, other patients with asthma may display a non-TH2 type 
inflammatory response characterized by neutrophilic inflammation, typically with the 
involvement of TNF-alpha [106], and TH-17 cells and the elaboration of IL-17A, IL-17F and IL-
22 [9].  Patients with severe asthma may have high levels of IFN- in their airways, suggesting 
the role of infection in driving disease [219].  The resulting inflammation of the airway results in 
airway wall edema, inflammatory cellular infiltration, and mucus hypersecretion.  There is also 
reticular basement membrane thickening with collagen deposition in the subepithelial space.  































































Deposition of proteoglycans and glycosaminoglycans is also found in this region of the airway 
wall, and has been correlated with the severity of asthma, decline in FEV1 [105] and airway 
hyperresponsiveness [107].  The consequence of these inflammatory events is airway luminal 
narrowing, with resultant airflow limitation.  Ongoing inflammation and injury to the airway 
epithelium may lead to activation of the epithelial/mesenchymal trophic unit, resulting in 
remodeling of the airway [30]. Airway remodeling involves increased vascularity, subepithelial 
myofibroblasts, fibrocytes, goblet cell hyperplasia, and increased airway smooth muscle mass 
[195].  Mechanical stress of airway epithelial cells in vitro has also been shown to elicit a 
remodeling response in tissue fibroblasts, which suggests that alterations in mechanical stress in 
the lung can augment matrix remodeling of the airway [246].  Such changes would be expected 
to stiffen the airway, and indeed decreased airway distensibility has been shown in some [35, 
116, 129, 280, 287], but not all [284] studies of patients with asthma.  In addition, mechanical 
compression of airway epithelium appears to contribute to ASM proliferation and contractility 
[149].  Recently, another type of abnormal airway epithelial cell behavior has been observed, 
known as jamming.  In vitro, healthy epithelial cells are very mobile and fluid-like, but airway 
epithelial cells from patients with asthma appear less motile and jammed in place.  The clinical 
significance of this behavior is unclear, but it appears to be modulated by mechanical stress such 
as might occur during bronchoconstriction [197, 199].  
The inflammation involved in asthma extends from the distal airways to the lung parenchyma 
[92, 143].  This inflammation differs between patients with controlled vs. non-controlled asthma 
with uncontrolled asthma involving more myofibroblasts and increased percentage of collagen, 
versican and decorin in the lung parenchyma [282].  Other studies have shown increased 































































myofibroblasts in both fatal and non-fatal asthma compared to healthy controls [18], and a wide 
distribution of eosinophils throughout the entire airway tree extending to the peribronchial 
parenchyma in fatal asthma, along with mast cells and neutrophils in this region [19].  A 
disrupted elastic fiber network of the lung parenchyma in patients with fatal asthma, along with 
peribronchial inflammation surrounding the small airways, may lead to loss of functional 
mechanical linkage between airway and surrounding parenchyma, leading to effective unloading 
of airway smooth muscle and nearly unopposed bronchoconstriction [170].  In addition, severe 
asthma has been associated with loss of elastic recoil of lung that appears to be due to 
microscopic emphysema that is not evident on pulmonary function testing (i.e., by the diffusing 
capacity of the lung for carbon monoxide test (DLCO)) or by chest CT imaging [80].   
Despite the solid evidence of airway and parenchymal inflammation in asthma, there are poor 
relationships between airway inflammation and asthma severity [281] or AHR [4, 38].  This fact 
emphasizes the complex nature of the clinical expression of asthma, which cannot be fully 
explained by structural abnormalities and inflammation alone.  Additional factors, to be reviewed 
in this paper, include more subtle manifestations of abnormalities in lung mechanics, as well as 
the emergence of other lung properties that characterize this complex disease.
Airway Narrowing in Asthma
Airway Narrowing and Resistance to Airflow































































The fundamental problem in asthma is excessive narrowing of the airway.  Based on Ohm’s 
Law, the resistance to airflow is equal to the driving pressure divided by the flow.  When flow is 
laminar, we can apply Pouseille’s Law to describe the relationship between flow (  pressure 𝑉),
(P) and resistance as they relate to the length (L) and radius (r ) of the conduit, as well as the 
density and viscosity of the gas (Equation 1):
 Equation 1∆𝑃 = 8𝜇𝐿𝑉/𝜋𝑟4
The critical role of airway diameter in determining the resistance to flow is seen easily by the 4th 
power inverse relationship of airway radius to airway resistance.  Thus, small changes in airway 
diameter result in large changes in airway resistance.  These changes subsequently result in 
multiple manifestations of abnormal lung mechanics (Table 1).
Airway narrowing results in wheezing and increased resistive work of breathing.  Wheezing 
results from the high frequency vibration of the airway wall as it oscillates between narrow and 
less narrow diameter within a region of airway narrowing that is so severe that the airway walls 
nearly touch each other.  In such a region, the velocity of gas flow increases, resulting in a drop 
in intraluminal pressure due to Bernoulli’s principle, which results in further airway narrowing.  
Meanwhile, the ongoing flow of air eventually builds up enough pressure to push the airway wall 
apart again, and the cycle repeats, resulting in a high frequency vibration of the airway wall 
around 400 Hz and the clinical sound described as a wheeze [101].  































































Airway narrowing results in expiratory airflow limitation [204].  The mechanism of flow 
limitation is usually described based on the development of an equal pressure point within the 
airway along the path of flow from alveoli to mouth [174]. Because the airways are 
compressible, the falling pressure gradient from alveoli to mouth results in a point along the 
airway where inside pressure equals outside pressure surrounding the airway.  From this point on 
distally toward the mouth, the outside pressure now exceeds the inside pressure, and the airway 
narrows. Due to Bernoulli’s principle, gas velocity must increase within the narrowed airway 
segment, which results in a drop in pressure within the segment in order to conserve net energy.  
This drop in pressure results in further airway narrowing. Thus, a cycle is established of airway 
narrowing during exhalation, which limits flow.  Another mechanism of flow limitation that 
occurs is due to wave speed theory [60].  This theory states that gas flow cannot exceed the 
speed with which the pressure perturbation travels within the walls of a compressible airway.  
Maximal flow is then governed by airway diameter, airway wall compliance and gas properties, 
all of which relate to maximal flow described by wave speed theory.
Expiratory flow limitation may occur not only during forced exhalation, but also at rest.  Indeed, 
expiratory flow limitation during tidal breathing may occur in patients with asthma and COPD 
and even otherwise healthy people with obesity [165], contributing to shortness of breath among 
these groups. 
Airway narrowing not only results in flow limitation and wheezing, but also increased work of 
breathing.  The work of breathing is due to the increased pressure required to move air through 
narrowed regions, as well as the development of unequal time constants throughout the lung.  































































The time constant is the product of resistance (R) and compliance (C), and relates to the time 
necessary to fill or empty the region in question. With increased R, it takes more time for air to 
flow into or out of the airway segment.  With increased C, it takes more time to fill or empty the 
lung volume served by the airway segment.  Unequal time constants result in decreased dynamic 
compliance, especially with increasing breathing frequency (frequency dependence of 
compliance) [87, 294]. This translates functionally into increased work of breathing.
Airway narrowing with resultant prolonged time constants throughout the lung also results in gas 
trapping at rest, and dynamic hyperinflation with activity.  The latter is especially significant 
because it is the most important factor contributing to dyspnea on exertion [155] and impaired 
activities of daily living [261].  With increased air trapping over time, the diaphragm becomes 
more inefficient at contraction, and increased intrathoracic pressures may also reduce preload 
and cardiac output.  Interestingly, dynamic hyperinflation in response to methacholine has been 
shown to occur without expiratory flow limitation [248], and may be related to persistent 
activation of inspiratory muscles, raising FRC perhaps to reduce airway resistance, expiratory 
flow limitation and/or airway closure [194, 209].
Airway narrowing is typically uneven in nature, leading to uneven distribution of time constants 
throughout the lung and ventilation heterogeneity, which is a key component of abnormal lung 
mechanics in asthma.  Ventilation heterogeneity will be discussed in more detail below. 
Detection of Airway Narrowing































































There are multiple ways to measure airway narrowing or its consequences.
Spirometry
Airway narrowing is usually inferred from spirometry, where the reduction in airflow results in a 
decrease in the ratio of FEV1/FVC.  This empiric measure was first described by Tiffaneau and 
is sometimes referred to as the Tiffaneau index.  Because it is measured during a forced 
exhalation, maximal airflow becomes effort independent once about 20% of the vital capacity 
has been exhaled due to the development of airway narrowing and flow limitation.  The FEV1 
occurs well within the effort independent portion of the flow-volume relationship, thus rendering 
it especially robust as a measure of airway function.  While the GOLD guidelines define the 
normal range of FEV1/FVC as > 0.7 (https://goldcopd.org/), the ATS/ERS have defined the 
statistical 5th percentile of the distribution of values in a normal healthy population as the lower 
limit of normal [58].  Importantly, the FEV1/FVC ratio declines with age, so the concept of 
using the lower limit of normal is more realistic.  Another way to describe the lower limit of 
normal is to equate the 5th percentile with the number of standard deviations below the mean, 
which is 1.64 SD [217].  This number is called the z-score. Thus, the LLN of the FEV1/FVC 
ratio is a z-score of -1.64. Classically, the FEV1 and the ratio of FEV1/FVC have been thought 
to reflect airway narrowing, and, in particular, large airway (> 2mm diameter) narrowing.  This 
seems to have been confirmed by Brown and colleagues, who demonstrated that only changes in 
large airway dimensions by CT scan correlated with changes in FEV1/FVC and FVC  [37].  
Meanwhile, other studies involving functional imaging have shown that large airway constriction 
alone cannot account for changes in ventilation seen after bronchoconstriction, and some degree 































































of small airways involvement is necessary [250].  These types of studies trying to correlate 
structre and function all have intrinsic limitations that makes generalizing their results difficult, 
so it is not entirely clear which airways are involved in changes in FEV1 and FVC.
Airway Resistance
Airway narrowing may also be inferred from direct measures of airway resistance [120].  Airway 
resistance (Raw) is usually measured clinically by body plethysmography, but may also be 
measured by other techniques including forced oscillation and interrupter.  During body 
plethysmography, mouth pressure taken at a moment of no flow through the airway is measured 
as a surrogate for alveolar pressure, and flow through the airway is also measured.  Airway 
resistance is thus calculated as alveolar pressure divided by flow.  Since Raw is highly dependent 
on lung volume, Raw is more accurately expressed as specific Raw (sRaw), the product of Raw 
and the volume at which the measurement is made (thoracic gas volume, TGV), or specific 
airway conductance (sGaw), which is the reciprocal of Raw, Gaw, divided by TGV.  
Airway resistance can also be measured by the forced oscillation technique (FOT), during which 
an oscillating flow of gas of different amplitudes and frequencies is delivered at the mouth 
during spontaneous breathing [14]. The resulting pressures measured encompass the entire 
impedance of the respiratory system (Zrs), which is composed of real and imaginary 
components. The real component, which is that part of the pressure signal in phase with flow, 
reflects Newtonian resistance at higher frequencies (i.e. > 5Hz), and thus is a direct measure of 
overall airway resistance.  At frequencies below 5 Hz, resistance rises with decreasing frequency, 































































displaying frequency dependence of resistance, which is thought to reflect airflow heterogeneity, 
tissue viscoelasticity and airway wall shunting.  The imaginary component is that part of the 
pressure signal out of phase with flow and is known as reactance, which itself is composed of 
both elastance and inertance.  
Airway resistance may also be measured by the interrupter technique [142]. During this 
procedure, a patient breathes quietly through a mouthpiece and the flow of air is briefly 
interrupted by a shutter occlusion. Pressure is measured at this point, and is divided by the flow 
immediately prior to flow interruption according to Ohm’s Law to measure resistance. This 
technique provides a measure of respiratory system resistance, but the resistance specifically 
attributable to gas flow in the airways cannot be determined .
All of the above methods provide a measurement of overall airway resistance across the airway 
tree, with the caveats stated.  To measure airway resistance more specifically in the lung 
periphery, a more invasive measurement of airway resistance can be performed by inserting a 
catheter into a small airway to directly measure pressure and flow.  Using this method, Ohrui and 
colleagues demonstrated that the peripheral airways were hyperresponsive to methacholine 
[193].   A similar approach is by the wedged bronchoscope technique, in which a steady flow of 
gas is instilled directly into a wedged airway, generating a resultant pressure due to the resistance 
to outflow of gas via the collateral airways that serve the wedged segment [275].  The 
relationship of pressure divided by flow is the overall resistance in the peripheral airways that 
conduct collateral flow out of the segment.  Since these peripheral airways are thought to be the 
respiratory bronchioles, this technique measures resistance in these small, peripheral airways.  































































This technique has shown that peripheral airway resistance is elevated in asthma, even in those 
patients with normal spirometry, and that the peripheral airways are hyperresponsive to stimuli 
such as histamine [273], cool dry air [124], and bradykinin [19].
Imaging
Airway narrowing may also be assessed directly by imaging using CT.  FEV1 is correlated with 
airway wall measurements of the more distal 4th to 6th generation of airways [104].  Airway 
narrowing has been found to be more heterogeneous in asthmatic than in healthy individuals 
[135]. Optical coherence tomography (OCT) is a relatively new technique that involves imaging 
the airway wall at the time of bronchoscopy and has yielded insight into airway wall structure 
and mechanical properties related to airway narrowing [284].
Lung Volumes
As discussed, the consequences of airway narrowing are airflow limitation, seen by spirometry, 
and increased airway resistance, measured by various techniques.  The important consequence of 
gas trapping is usually detected by measuring lung volumes, in particular the ratio of RV/TLC.  
Dynamic hyperinflation is detected by rising end-expiratory lung volume (EELV) during 
exercise, which may be measured indirectly by the inspiratory capacity [41].  With increasing 
dynamic hyperinflation, EELV rises, resulting in a fall in IC.  Air trapping is seen visually by CT 
scanning that quantifies air trapping by CT density <850 HU at FRC [40, 43].  































































Mechanisms of Airway Narrowing in Asthma
The traditional concept of airway narrowing is based on two main mechanisms, one relating to 
bronchoconstriction from activation and shortening of airway smooth muscle (ASM), and the 
other related to luminal narrowing from surrounding airway wall thickening from edema and 
inflammation.  However, we now understand that additional mechanisms are also involved [97] 
(Figure 2).
Airway Smooth Muscle Dynamics
There is no doubt that ASM contraction results in airway narrowing by mechanical constriction 
of the airway [4].  The importance of this mechanism is easily realized by the fundamental 
clinical success of treating airway narrowing with beta agonists that relax ASM and allow 
bronchodilation.  Airway smooth muscle is arranged concentrically around the airway wall, but 
also spirals in a longitudinal direction, such that activation of ASM results in both narrowing and 
shortening of the airway. For many years there has been controversy about whether there is 
increased mass of ASM (hypertrophy, from increased cell size, and hyperplasia from increased 
cell number), or whether there is simply increased activation or strength of ASM shortening.  It 
now appears that both mechanisms are involved [4, 213]. In addition, the velocity of ASM 
shortening is increased in patients with asthma.  Furthermore, increased basal tone in ASM is 
associated with increased AHR and the reduced ability to bronchodilate in response to a deep 
breath [77].  However, animal work has demonstrated that ASM dynamics at the cellular level 































































alone cannot fully explain airway narrowing, implicating important roles for the intact airway 
wall and surrounding structural environment [25, 150]. ASM function is also directly linked to 
airway inflammation and remodeling [188].
In addition, the load against which ASM must react also is an important determinant of airway 
narrowing.  With decreased loads, ASM will constrict more for a given force of contraction.  
There are both internal and external loads to ASM [97, 127].  Internal load is determined by the 
structural elements of the airway wall, including the ASM itself, as well as the buckling of the 
basement membrane. External load is determined by the structural and functional forces that 
resist ASM constriction outside the airway wall.  This linkage between airway and surrounding 
lung parenchyma is referred to as airway-parenchymal interdependence [196].  In asthma, 
external ASM loads are thought to be decreased because of peribronchial inflammation and 
edema, which serve to uncouple the airway wall from the surrounding alveolar tethering units, a 
phenomenon referred to as loss of interdependence.  Loss of interdependence not only allows the 
ASM to constrict more for a given force, but also uncouples the airway wall from the lung 
parenchyma such that the airways dilate less in response to deep inhalation.  With less 
bronchodilation from a deep breath, ASM is maintained in a more constricted state for longer 
periods of time, which may lead to further difficulty in stretching the ASM during a deep 
inhalation.  Over time this may lead to remodeling of the ASM such that it is “frozen” in a “latch 
state” of actin-myosin interaction that hinders relaxation [4].
Airway Inflammation and Edema































































Inflammation and edema of the airway wall will increase the thickness of the wall. The 
consequence of this is that for a given degree of ASM constriction, the luminal diameter will 
decrease more due to geometric factors [15].  Inflammation and edema also contribute to altered 
contractility of ASM. Inflammation and edema of the airway wall and peribronchial region are 
thought to be the main reason for loss of airway-parenchymal interdependence [213] (see below). 
Airway Remodeling
The combined influences of changes in ASM, airway inflammation and edema, as well as 
changes in other airway wall components, including the epithelium, mucus glands, basement 
membrane, and blood vessels, all contribute to airway remodeling [71].  Such remodeling 
appears to have an additive effect on airway narrowing when in the presence of active 
inflammation [278].  Airway remodeling contributes to airway narrowing by not only increasing 
airway wall thickness, but also changing airway wall compliance [138].  Indeed, in asthma there 
is less distensibility of airway walls, which is thought to be due to remodeling [35, 131].  This 
reduced distensibility allows less dilation in response to a deep inhalation, even in the presence 
of normal airway – parenchyma interdependence.   Reduced dilation in response to a deep 
inhalation to revere bronchoconstriction may also be due to more rapid constriction during 
exhalation [110].   Interestingly, increased stiffness of the airway wall may also be protective 
against bronchoconstriction [31].  In obesity, patients with asthma may have more compliant 
airway walls, leading to more severe airway narrowing and either actual or functional (i.e., very 
prolonged time constants) closure [1].  There is clinical evidence that repeated 































































bronchoconstriction, in the absence of airway inflammation, leads to airway remodeling [86], but 
this finding has not been replicated in experimental animals [168]. 
Loss of Airway-Parenchymal Interdependence
As mentioned previously, loss of interdependence may unload ASM and lead to more severe 
airway narrowing for a given force of contraction, as well as failure to dilate in response to a 
deep inhalation. The failure of patients with asthma to bronchodilate in response to a deep breath 
has been measured most directly by noting changes in Raw before and after a deep breath [182].  
In 1981, Fish suggested that the failure to bronchodilate in response to a deep breath may 
contribute to AHR [72].  The response to a deep breath depends not only the linkage of 
parenchyma to airway wall and the distensib lity of the airway, but also on the speed of airway 
re-narrowing [113, 208, 224].
The response to deep breath has also been inferred by noting changes in airflow at a given lung 
volume when comparing flows measured following a deep (maximal, M) inhalation, compared to 
flows measured following a submaximal (partial, P) inhalation, which avoids the full, deep 
breath involved in conventional spirometry. When plotted on the same volume axis, the ratio of 
flow after a deep breath vs. after a partial breath is greater than one (M:P > 1) if bronchodilation 
occurs, and is less than one (M:P < 1) if bronchoconstriction occurs.  
One explanation given for the response of the airway to deep inhalation is related to whether or 
not the ASM relaxes or perhaps even constricts following a deep breath.  A relaxation response 































































may be due to production or release of nitric oxide by ASM [227] or increased surfactant 
response to DI [45].  Another explanation is more complicated and relates to the ratio of airway 
to parenchymal hysteresis [76].  Hysteresis refers to the difference in the pressure vs. volume 
relationship observed when one inhales vs. exhales.  If the lung were a perfect elastic substance, 
the PV relationship during inhalation would be the same as that during exhalation.  However, as 
a viscoelastic material, together with the properties of surfactant, the PV curve on inhalation 
demonstrates lower compliance than that on exhalation, and generally forms a loop.  
The airway wall can be considered to have similar material properties.  The hysteresis of each 
structure can be thought of as reflecting the elastic recoil of that structure [207].  Thus, if the 
hysteresis of both airway and lung were the same, then there would be no response to a deep 
breath, and M:P = 1, because the inward airway recoil would balance the outward parenchymal 
recoil. If airway hysteresis exceeded parenchymal hysteresis, then the airway would be at a 
larger diameter after a deep breath than before, a bronchodilator response with an M:P ratio > 1, 
because airway recoil in would lag behind the restoration of parenchyma recoil out; i.e., the 
response would be dominated by the outward parenchymal force.  If airway hysteresis were less 
than parenchymal hysteresis, then the airway diameter would be smaller after a deep breath than 
before, a bronchoconstrictor response with an M:P ratio < 1, because parenchymal recoil out 
would lag behind airway recoil in; i.e., the response would be dominated by the inward recoil of 
the airways (Figure 3).
Healthy subjects and those with mild asthma typically bronchodilate in response to a deep 
breath, with M:P > 1.  Patients with moderate to severe asthma either don’t bronchodilate, or 































































may even constrict after a deep breath (M:P < 1).  In the latter case, inflammation of the airway 
wall and surrounding parenchyma is thought to result in a situation where there is both 
uncoupling of the airway from the parenchyma, thus not allowing the parenchyma to pull on and 
tether open the airways, as well as increased hysteresis of the parenchyma.  This latter effect 
creates a situation such that after the deep breath, the ASM constricts to a greater extent before it 
is sufficiently opposed by the outward force of the surrounding lung parenchyma, thus allowing 
a net bronchoconstriction to occur.  
These responses to deep inhalation have consequences for patients with asthma [46]. First, they 
may not be able to relieve bronchoconstriction by a deep inhalation, and this lack of response to 
deep inhalation may, likewise, not protect them from bronchoconstriction.  This 
bronchoprotective effect of DI in healthy subjects is lost in patients with asthma [128].  Studies 
in healthy subjects suggests that the bronchoprotective effect of DI is related to protection 
against airway closure rather than a direct effect on airway narrowing [45].  Second, the latch 
state of ASM may develop from inability to stretch ASM over periods of time, although this is 
only inferred from in vitro data [74, 132, 144].  A third consequence of loss of interdependence 
is potential risk of sudden, catastrophic airway narrowing and closure [269].  This may be due to 
reduced ASM load and inability to bronchodilate with a deep inhalation.  Indeed, patients with 
near fatal asthma have been shown to have increased lung compliance with no evidence of 
parenchymal emphysema by measurement of DLCO or by high resolution CT scan. On 
microscopy, such patients may have disruption of alveolar elastic fibers, which would otherwise 
serve to provide interdependence with the airway through a mechanical tethering effect [80].  
With decreased interdependence, the airways would be expected to be more uncoupled from the 































































surrounding lung parenchyma, leading to increased bronchoconstriction for a given stimulus and 
higher risk of a severe asthma episode.  Another possible consequence of loss of interdependence 
is related to the effect of DI in obese patients with asthma.   Specifically, the effects of a DI in 
obesity appear to depend on whether the DI is performed before or after methacholine challenge. 
If performed before, the DI enhances the response, whereas if performed after methacholine 
challenge, DI protects against the response [235]. The mechanisms involved in this differential 
response and how it relates to obesity are unknown, although it is speculated that the DI before 
challenge leads to opening of peripheral airways that then receive more methacholine than they 
would have otherwise, leading to enhanced bronchoconstriction, whereas the DI after challenge 
is able to relieve bronchoconstriction.
Dynamic Changes in Airway Narrowing over Time
Airway narrowing is not a static phenomenon. In fact, asthma is clinically defined by variable 
airflow limitation, which is typically relieved by bronchodilator, and AHR, the enhanced 
propensity and response to bronchoconstriction after exposure to triggering stimuli.  This can 
make a diagnosis of asthma challenging because any one measurement of airway function at one 
point in time may or may not reveal any abnormalities.  Accordingly, to help in making a 
diagnosis of asthma, the airways are typically challenged with bronchodilator, or likewise with 
bronchoconstrictor.  One may also observe the dynamic nature of airway narrowing in patients 
with asthma during exercise.  Increased physical activity results in increased metabolic and 
hence ventilatory demands. The latter are met by increasing both rate and volume of breathing.  
With airway narrowing and unequal time constants throughout the lung, some regions will 































































require more time to fill and empty completely, and such time will become more and more 
limited as the respiratory rate increases. The result may be a rise in EELV from insufficient time 
for exhalation, a phenomenon known as dynamic hyperinflation.  Dyspnea becomes limiting 
during exercise when dynamic hyperinflation reaches a critical level and the inspiratory reserve 
volume falls to minimum [151].  Interestingly, there are data to also support another mechanism 
of hyperinflation, which may also occur with exercise, which is sustained inspiratory muscle 
activity [205].  Presumably this response helps maintain a higher EELV, which would result in 
reduced airway resistance from breathing at higher lung volumes.  A recent study examined the 
relationship between changes in airway resistance, lung volume and airway diameter in the 
setting of dynamic hyperinflation and concluded that the increase in EELV was not passively 
related to increased airway resistance and reduced time for emptying, but rather was an active 
process, possibly due to increased inspiratory muscle activity, designed to increase EELV to 
maintain open the least stable airway, [194].
Variability in airway narrowing may also occur across different time scales. The FOT has been 
used to demonstrate that Zrs varies across minutes in asthmatic patients compared to healthy 
controls, presumably reflecting variability in the degree and distribution of airway narrowing.  
The complexity of lung impedance over the course of a 2 minute measurement also differs in 
asthma as measured by increased approximate entropy [84, 265].  Many studies have 
demonstrated variability in peak expiratory flow across hours during the day, and day to day over 
weeks and months.  This variability can be quite striking, particularly in asthmatics with poor 
control of their disease, or in those with nocturnal symptoms [169]. In the latter case, PEF 































































variation occurs in wide swings according to what appear to be underlying circadian rhythms 
[169].  
Recently, different groups have assessed the time course of PEF variability and found it to follow 
a power law, suggesting a fractal pattern over time that might be reminiscent of the fractal 
structural form of the airway tree (Figure 4).  By applying a signal processing technique known 
as detrended fluctuation analysis, asthmatic patients may have predictable patterns of fluctuation 
that might provide a probabilistic estimate of future exacerbations [126, 251].  Other methods of 
quantifying variability of lung function over time, such as sample entropy [84], or fluctuation 
analysis with FOT [266], have shown that such variability is associated with asthma exacerbation 
frequency.
Airway Closure
At the extreme of airway narrowing is airway closure.  Airway closure may describe the actual 
physical closure of airways, but also commonly reflects functional closure; i.e. such extreme 
narrowing of airways that airflow is essentially minimal and the airway behaves as if it is 
actually closed. Airway closure has been detected in asthma and is increasingly thought to play a 
significant role in the pathophysiology and clinical manifestations of the disease.
Detection of Airway Closure
Spirometry, Lung Volumes - FVC, RV/TLC































































Airway closure is measured from spirometry as the forced vital capacity (FVC), representing the 
volume forcibly exhaled from maximal inspiration i.e. the volume between total lung capacity 
(TLC) and residual volume (RV). As such, the interpretation of FVC as a measure of airway 
closure is based upon the assumption that changes in FVC are due to changes in RV without a 
change in TLC. This appears to be a valid assumption in patients with asthma during indirect 
bronchial challenge, since methacholine causing a ~30% fall in forced expiratory volume in 1 
second (FEV1) did not alter TLC [140]. However, baseline TLC can be substantially increased in 
asthmatics at baseline and during an acute exacerbation so that the FVC greatly underestimates 
the increase in airway closure [37, 291]. 
In order to more reliably measure airway closure, direct measurement of TLC and RV is 
required. This is most commonly performed with either body plethysmography or inert gas 
dilution. Body plethysmography involves placing a patient inside an airtight box and having 
them breathe against a closed shutter. By measuring the changes in box pressure during 
inspiration and expiration and invoking Boyle’s law (the product of pressure (P) and volume (V) 
under initial circumstances (P1, V1) will equal the product of P and V under another set of 
circumstances (P2,V2); i.e., P1V1 = P2V2), the lung volume at which panting occurred can be 
measured. Instructing the patient to then perform a full inspiratory and expiratory maneuver 
allows calculation of other lung volume subdivisions, including TLC and RV.  Notably, since the 
body plethysmography technique assumes an equilibration of mouth and alveolar pressure during 
measurement of TGV, this method may overestimate TGV in patients with airflow limitation in 
whom such equilibration may not occur during the time period of measurement [230].  Another 































































technique to measure lung volumes is by the inert gas dilution method, which utilizes the 
principle of conservation of mass (the product of concentration (C) and volume (V) under initial 
circumstances (C1, V1) will equal the product of C and V under another set of circumstances 
(C2,V2); i.e., C1V1 = C2V2). One such method involves the patient breathing a known volume 
and concentration of an inert gas in a closed-circuit. Once equilibrium has occurred, end-
expiratory gas concentration is used to measure lung volume. Another method is to have the 
patient breathe in pure oxygen and wash-out the resident nitrogen (N2) in the lung, which 
essentially involves applying the same principle of conservation of mass.  However, inert gas 
dilution only measures lung volume that is communicating with the mouth/atmosphere and 
therefore severe airway narrowing and/or airway closure can substantially underestimate lung 
volumes calculated by this technique.  
Single Breath Nitrogen Washout (SBNW)- Closing Volume, Closing Capacity 
The measurement of airway closure based on the single breath nitrogen washout (SBNW) test is 
founded on the principle that there is a minimum critical pressure below which terminal 
bronchioles close trapping gas within the lung [108]. The absolute lung volume at which an 
airway reaches this critical closing pressure is not homogenous as a result of pleural pressure 
gradients due to gravity and interdependence between lung regions. However, the volume range 
over which airway close is known as the closing capacity (CC), usually expressed as a 
percentage of TLC.  When combined with measurement of RV, the absolute lung volume at 
which airways begin to close, termed closing volume (CV), can be calculated i.e. CV = CC – 
RV, and is usually expressed as a percentage of VC. 































































The SBNW test is performed by inhaling 100% O2 from RV to TLC before expiring at a constant 
rate from TLC back to RV (Figure 5). At RV, the distribution of lung volume is dependent upon 
a gravity-related gradient so that prior to the inhalation of 100% O2 lung volume is greater in 
upper lung zone > mid-lung zone > lower lung regions [177]. This leads to an apical-basal 
concentration gradient for N2, with greater N2 concentration in the upper lung than lower lung 
zones. Furthermore, inspiration is preferentially distributed to the upper lung zones up to ~20% 
of VC [177] so that preferential distribution of the anatomic dead space gas, which does not 
contain O2, further contributes to a greater nitrogen concentration in upper zone airways.  Then, 
as expiration from TLC begins, the first gas out is anatomic dead space still filled with 100% O2 
and thus no N2.  Gas then comes from all regions of the lung, with varying mixtures of O2 and 
N2, as expiration proceeds.  As expiration approaches RV, the gravity-dependent differences in 
pleural pressure mean that airways in lower lung regions will begin to close (earlier) at higher 
absolute lung volumes. This onset of airway closure produces a rise in the expiratory N2 
concentration as expiration now more heavily reflects airways in the upper lung zones with a 
higher N2 concentration.
 
Measurement of N2 concentration throughout the entire expiratory trace provides the traditional 
four phase expiratory trace as described by Fowler [73].  Phase I represents dead-space and 
contains only 100% O2, Phase II is the transition from dead-space to alveolar gas and Phase III is 
alveolar dead space with the slope of this “plateau” reflecting the extent of ventilation 
heterogeneity. At the end of Phase III there is the aforementioned sudden increase in N2 































































concentration which is the Phase IV slope. The inflection point between Phases III and IV is CV 
and the volume over which Phase IV slope occurs is the closing capacity.    
Peripheral Airway Resistance – Catheter Method
Airway closure has been inferred from direct measurement of changes in peripheral airway 
resistance (Rp) using the wedged bronchoscope technique.  Kaminsky and colleagues modeled 
the change in Rp as a function in time following cessation of airflow through the wedged 
bronchoscope [121].  The plateau of pressure remaining within the wedged segment is assumed 
to be due to airway closure.  In modeling of the response of the lung periphery to the direct 
instillation of cool, dry air to mimic hyperpnea, asthmatic participants were found to have higher 
Rp and plateau pressure both at baseline and in response to cool, dry air than healthy, control 
participants.  These findings implicate increased narrowing and closure of collateral channels 
both at baseline and in response to cool, dry air in the wedged segment in asthma.
Forced Oscillation Technique – Changes in Elastance
The forced oscillation technique applies pressure oscillations to the airway opening in order to 
measure respiratory system impedance. This can be further partitioned into its components of 
respiratory system resistance and reactance, with the latter reflecting the contribution of 
compliance (reciprocal of elastance) and inertance. Respiratory system compliance comprises 
both lung tissue compliance, which equals the sum total compliance across parallel alveolar 
units, and the extent of gas compressibility within the lung. Therefore, one would expect that a 































































larger lung, due to more alveolar units in parallel and greater extent of gas compression would 
result in increased compliance (reduced elastance/less negative reactance). Indeed, population 
predicted equations for reactance include height as a surrogate of lung volume [36]. Similarly, 
one would expect that airway closure, which removes the tissue compliance and gas compression 
contributions of alveolar units, would lead to a reduction in compliance (increase in 
elastance/more negative reactance).  This is supported by computational modelling in which 
changes in oscillatory compliance were only minimally affected by airway narrowing but were 
extremely sensitive to heterogeneous peripheral airway closure [159, 253].  (Figure 6).  In 
addition, data from animal models have shown that measures of compliance/elastance 
correspond to the extent of airway closure measured by lung imaging [62, 158]. In humans, 
expiration from TLC to RV reveals a critical volume below which the magnitude of reactance 
dramatically worsens (becomes more negative) and it is thought that this volume corresponds to 
closing capacity [186] (Figure 7).  Consistent with this is the finding that reactance measured 
during tidal breathing is more negative in obese subjects in whom FRC is below CC [166], 
suggesting that reactance is sensitive to airway closure and/or expiratory flow limitation 
occurring during tidal breathing. In people without respiratory disease, there is an expected 
inverse relationship between reactance and FRC measured by plethysmography [178]. However, 
in patients with COPD, in which airway closure is a characteristic feature, reactance was not 
correlated with FRC but was instead correlated with expiratory reserve volume and alveolar 
volume. These findings suggest that reactance is, in part, determined by the extent of lung 
volume communicating with the airway opening, further supporting the use of reactance as a 
measure of airway closure.  































































Imaging – CT, SPECT, PET, 3He-MRI
There are several different imaging modalities for acquiring 3D volumes of the lung. These 
include Computed Tomography (CT), Single Photon Emission Computed Tomography 
(SPECT), Positron Emission Tomography (PET) and 3He-Magnetic Resonance Imaging (MRI) 
[137] . CT imaging is based upon differences in density between the airway-filled lung and 
surrounding anatomic structures. After defining the outline of the lung based on a standard 
Hounsfield unit, CT lung volume is measured as the total number of voxels × voxel volume. As 
such, CT lung volume measures all volume within the lung at that specific lung volume, 
regardless of whether it is communicating with the airway opening or trapped behind closed 
airways. Indeed, there is no systematic difference between lung volume calculated from CT 
acquired at FRC and FRC measured by body plethysmography [69]. In contrast, SPECT and 
3He-MRI imaging involve inhalation of a specific contrast agent which enters ventilated airways 
and thus reflects the volume of lung in communication with the airway.  Both have yielded 
impressive images of the distribution of ventilation (Figures 8, 9).  PET on the other hand 
involves tracing nitrogen washout that has been injected intravenously as 13N, and thus reflects 
both blood flow and ventilation.  Following image segmentation to provide an outline of the 
lung, either guided by CT or by semi-automated software, ventilated lung volume and non-
ventilated lung volume (also known as ventilation defects) can be calculated.  It is therefore not 
surprising that there is no systematic bias between ventilated lung volume measured at FRC by 
SPECT and FRC measured by nitrogen washout [69]. However, it should be noted that not all 
ventilation imaging modalities are equal. SPECT imaging involves inhalation of Technegas, a 
100nm radiolabeled carbon particle, which follows gas distribution during inhalation but “sticks” 































































to the lung where it remains for at least 20 min [3].  As such, SPECT reflects the ventilation 
distribution during inhalation and is minimally affected by the supine posture required for 
imaging. In contrast, 3He-MRI ventilation imaging requires inhalation of a contrast agent at the 
time of image acquisition. Therefore, 3He-MRI imaging reflects the distribution of ventilation 
while in a specific, horizontal position; i.e. supine, decubitus or prone posture. Interestingly, a 
recent study reported that the volume of lung affected by constriction following methacholine 
challenge was not different when methacholine was inhaled in the prone or supine posture, or 
whether imaging was performed supine or prone suggesting that posture during inhalation of 
spasmogen doesn’t determine ventilation pattern  [78].  In contrast, the posture during imaging 
determined the pattern of ventilation pattern. 
Structural-Functional Correlation of Airway Closure
The significance of imaging findings in asthma (structural) may be appreciated by correlating 
such findings with those of functional measurements like FOT and MBNW.  Such functional 
imaging studies have validated the importance of airway closure in asthma.  For example, 
Farrow and colleagues used SPECT and MBNW to assess the response AHR to methacholine, 
and found that methacholine resulted in airway closure as seen by loss of ventilation on SPECT 
which was determined by the baseline level of ventilation heterogeneity in peripheral conducting 
airways (pre-methacholine Scond) (Figure 9) [69].  The authors also found that the increase in the 
proportion of poorly ventilated lung regions was associated with the change in ventilation 
heterogeneity in the peripheral acinar airways (increase in Sacin) [70].  These combined findings 
directly implicate airway closure and heterogeneous airway narrowing by both imaging and 































































MBNW.  Likewise, Tgavalekos and colleagues have demonstrated that closure or near-closure of 
small airways must occur to explain the simultaneous findings of ventilation defects by PET 
images and the changes in lung resistance and elastance between 0.15 and 8 Hz [250].
Mechanisms of Airway Closure
Clearly, airway narrowing may lead to airway closure if the narrowing results in complete 
obliteration of the airway lumen.  However, multiple factors are involved in determining whether 
an airway will close.  First one must consider the forces causing airway narrowing. These 
include the bronchoconstriction caused by ASM constriction, and the narrowing of the lumen by 
airway wall thickening, which itself may be related to airway inflammation, remodeling or 
edema.  In addition, any thickening of the airway wall will enhance the ASM constrictive 
response by geometric considerations [283].  Second, the surface tension of the airway lining 
fluid plays an important role in maintaining airway patency [296].  As the radius of curvature of 
the airway lumen decreases, the surface tension of the lining fluid increases according to the Law 
of LaPlace.  However, surfactant within the lining fluid helps to stabilize the airway by lowering 
the surface tension as the radius decreases.  The plasma proteins associated with inflammation in 
asthma have been shown to reduce the ability of surfactant to lower surface tension, making it 
more likely that the airway lumen may collapse shut.  In addition, bridging fluid may join the 
walls and result in airway closure [288].  Thus, airway closure may be caused by not only simple 
bronchoconstriction but also by fluid bridging and surfactant dysfunction.
Consequences of Airway Closure































































Airway closure or near closure will have a number of clinical consequences.  As discussed, 
airway closure will lead to gas trapping and hyperinflation, which will markedly increase the 
work of breathing and worsen shortness of breath.  In addition, the normal hyperpnea associated 
with exercise will result in dynamic hyperinflation, worsening dyspnea on exertion and reducing 
exercise tolerance.  Airway closure is associated with more severe asthma [239, 240], risk of 
exacerbations [240] and poor control [130, 210].  Additionally, one would expect airway closure 
to have important implications for asthma treatment, since closed airways would not allow 
access for inhaled aerosol therapy [270, 276].  
Ventilation Heterogeneity
Ventilation heterogeneity refers to the unevenness of airflow and ventilation that occurs 
throughout the lung.  Since airway narrowing and airflow limitation occur in an uneven fashion 
in asthma, ventilation heterogeneity is an inevitable finding.  Ventilation heterogeneity has 
important consequences in asthma.
Detection of Ventilation Heterogeneity
Spirometry- Flow-Volume Loop Shape Parameters
Uneven ventilation is thought to contribute to the shape of the flow volume curve.  In intubated 
infants, the concavity of the flow-volume loop related to the degree of ventilation heterogeneity 































































[34].  New spirometric indexes related to the shape of the flow-volume curve have been ascribed, 
in part, to ventilation heterogeneity in COPD [20].
Single Breath Nitrogen Washout (SBNW) – Slope Phase 3
The SBNW test has been described above in relation to detecting airway closure (Figure 5).  
Ventilation heterogeneity is thought to be reflected in the slope of Phase III of the washout 
curve.  If ventilation were entirely even, then all lung areas would empty simultaneously and 
evenly, and slope of Phase III would be flat.  However, as time constants vary throughout the 
lung, some regions will empty faster than others, resulting in a positive slope of Phase III.  An 
increased slope of Phase III has been described in poorly controlled asthma [29].   Since there is 
wide variability in the measurement of the slope of Phase III, it is felt to not have much clinical 
utility, but may still be valuable as a research tool.
Multiple Breath Nitrogen Washout (MBNW) – LCI, Scond, Sacin 
Unlike SBNW, the MBNW is performed during quiet breathing of oxygen (Figure 10).  Recent 
international guidelines have been published highlighting the importance of standardized 
technique. In this method, the slope of Phase III of each breath is successively measured over 
time, and slopes corrected for N2 concentration are plotted against the cumulative volume of gas 
exhaled adjusted for FRC (called “lung turnovers”).  The slope of this plot between lung 
turnovers 1.5 and 6 is felt to represent the heterogeneity of ventilation at the level of the 
peripheral conducting airways, and is termed Scond.  The slope Phase III of the first breath 































































(minus the contribution of Scond at this point, numerically equal to Scond x lung turnover at first 
breath) is felt to represent the heterogeneity of the ventilation at the level of the junction between 
convective and diffusive gas flow occurring at the entrance to the acinar region, and is termed 
Sacin (Figure 11, 12).  In asthma, Scond and Sacin are associated with other measures of 
ventilation heterogeneity obtained by imaging or FOT, and with clinical outcomes such as 
asthma severity and asthma control [65, 68, 70, 94, 245, 268].  Another global measure that is 
calculated is the lung clearance index, LCI, which represents the number of lung turnovers 
necessary to clear nitrogen down to 1/40th of it starting value.  LCI is elevated in children with 
asthma despite good symptom control [218], but LCI is not able to discriminate proximal vs. 
peripheral ventilation heterogeneity like Scond and Sacin [272].  Interestingly, when SBNW and 
MBNW were compared in asthmatic subjects, MBNW indexes of uneven ventilation (LCI, 
Scond, Sacin) detected more abnormalities, but slope Phase 3 from SBNW was better associated 
with overall asthma severity [141].
Comparison of Alveolar Volume by Single Breath to TLC by Inert Gas Washout or Body 
Plethysmography (VA/TLC)
A measure of ventilation heterogeneity that is commonly obtained during routine pulmonary 
function testing is the VA/TLC ratio when both single breath DLCO and lung volumes are 
measured.  Since the VA is measured by gas dilution during a 10 second breath hold at TLC, VA 
should nearly equal TLC once any equipment and anatomic dead space is subtracted.  In a 
healthy lung, VA is approximately at least 85% of TLC. When VA/TLC is < 85%, VA is 
underestimating TLC likely due to insufficient time for gas distribution during the brief 10 































































second breath hold, which will be common among patients with uneven ventilation.  We have 
found that VA/TLC is correlated with AHR among general patients presenting to the clinical 
PFT lab [122].
Force Oscillation Technique- Frequency Dependence of Resistance and Reactance
The FOT also allows insight into ventilation heterogeneity. Based on computational modeling, 
low frequency (< 5Hz) impedance reflects more peripheral lung mechanics, with signals in the 
<1 Hz range reflecting mechanics of the small airways and tissue [159].  Frequency dependence 
of  resistance is seen at <1 Hz and is thought to be due to tissue viscoelasticity as well as 
ventilation heterogeneity [14]. The same is true of reactance at low frequency, particularly < 1 
Hz.  
Imaging – CT, SPECT, PET, 3He-MRI
Ventilation heterogeneity is perhaps best appreciated by various imaging modalities.  Uneveness 
of ventilation has been shown by CT scan, SPECT, PET and 3He-MRI (Figures 8, 9).  Each of 
these modalities has its own important strengths and limitations, but these methods provide 
important insight into ventilation heterogeneity in asthma and other lung diseases [134].  In 
conventional CT scan, Kaminsky and colleagues have shown that airspace heterogeneity, as a 
surrogate for ventilation heterogeneity, was increased following methacholine challenge [125].  
More recently, Dame-Carrol and colleagues demonstrated increased heterogeneity of airway 
narrowing by CT in asthmatics, again implicating increased ventilation heterogeneity [59].  PET 































































imaging takes place as N13 is washed out of the lung following intravenous injection during 
apnea.  These data provide information on both regional ventilation and perfusion and has 
yielded important insights through computational modeling about the size and location of airway 
narrowing and closure in asthma [249, 250].  SPECT is based on the topographic distribution of 
inhaled radiolabeled particles, such as the ultrafine carbon particle aerosol Technegas, or gases, 
such as xenon-133, and was one of the first techniques to demonstrate heterogenous ventilation 
in asthma [136].  3He-MRI relies on inhalation of 3He, which being a gas can spread by 
convection and diffusion. In addition to demonstrating heterogeneous ventilation and drop out of 
ventilation thought to be due to airway closure [157], 3He-MRI imaging allows an estimate of the 
dimensions of the alveolus as well as the degree of collateral ventilation using a measure known 
as the apparent diffusion coefficient (ADC) [277].   Recently, ventilation heterogeneity has been 
demonstrated by 3He-MRI to be common to both healthy and asthmatic patients following 
methacholine-induced bronchoconstriction, but the asthmatics were unable to reduce 
heterogeneity following a DI [258].
Mechanisms of Ventilation Heterogeneity
Uneven distribution of airway narrowing will result in ventilation heterogeneity.  Many factors 
may be involved, which include uneven ASM function along the airway tree [162, 163], 
variability in the degree of airway wall inflammation detected by exhaled NO in proximal vs. 
distal airways [216],  and variability in the nature of underlying anatomic inflammation and 
structural remodeling of the airway wall [200].  Gravity itself results in uneven ventilation and 
blood flow throughout the lung, even in health, although heterogeneity of both ventilation and 































































perfusion persist even in microgravity, indicating additional mechanisms [215].  Furthermore, 
because the airways and lung parenchyma are interdependent, the distribution of ventilation is 
determined by the complex pattern of airflow in the lung. One phenomenon that has been 
described is the avalanche behavior of the lung in the presence of uneven distribution of airflow 
and/or mechanical properties that can lead to sudden and catastrophic airway narrowing and 
closure [152, 269].  How such airflow evolves cannot be predicted by analysis of the simple sum 
of all the airways in the lung, and instead is a manifestation of the emergence properties of the 
lung behaving like any complex system [290] (Figure 13).   The combination of structural 
variability and functional variability determined by emergent properties was recently described 
by Donovan [64].  Finally, it is important to consider that ventilation heterogeneity is no doubt 
influenced by the uneven distribution of bronchoconstrictive agonists as they are inhaled into the 
lung [276].  
Consequence of Ventilation Heterogeneity
Ventilation heterogeneity in asthma has significant clinical consequences.  First, ventilation 
heterogeneity may lead to increased work of breathing by causing a functionally “stiff” lung 
[118].  In the case of uneven ventilation, some airways are more narrow than others, offering 
higher resistance to airflow, but at the same time more distended airways are stiffer, offering less 
compliance to accommodate gas flow.  Because of uneven ventilation, the apparent stiffness of 
the lung increases with increasing respiratory frequency, a phenomenon known as frequency 
dependence of compliance. This translates into dyspnea and increased work of breathing at 
higher respiratory rates, such as would be seen with exercise.   Second, ventilation heterogeneity 































































may predispose to abrupt development of ventilation defects from airway closure, which may 
lead to sudden worsening of asthma [290].  These defects may emerge as a consequence of the 
complex structure of the airway tree and the uneven distribution of airway narrowing.   
Ventilation heterogeneity, especially in the context of acute bronchospasm, also leads to 
imbalances in the ratio of ventilation (V) to perfusion (Q) [220]. In particular, the development 
of more low V/Q units in the lung leads to overall worsening of gas exchange, leading to 
hypoxemia and potentially hypercarbia.  In response, the drive to breathe results in increased 
ventilation, which is best accomplished by increased respiratory rate because tidal volume 
recruitment becomes more and more limited by dynamic hyperinflation. This chain of events sets 
up a vicious cycle of increased drive to breathe, increased respiratory rate, decreased time for 
emptying, increased gas trapping and development of dynamic hyperinflation.  Worsening 
dynamic hyperinflation leads to increased work of breathing, and the reliance on respiratory rate 
leads to rapid, shallow breathing and increased ratio of physiologic dead space to tidal volume 
ratio.  This, in turn, leads to less ventilatory efficiency, and ultimately to CO2 retention, which 
can further increase the drive to breathe. Thus, there ensues a worsening cycle of gas exchange 
that can ultimately lead to respiratory failure.  
Third, ventilation heterogeneity may contribute to AHR, which is discussed in more detail below 
in the section on AHR.  Fourth, ventilation heterogeneity is strongly linked to many aspects of 
asthma severity and control [2, 8, 67, 157, 245], perhaps through its influence on AHR, as well 
as its fundamental role in leading to the avalanche-like development of airway closure, as 
described earlier.  In addition, the response of lung function to deep inhalation is variable in 
asthma, and computational modeling suggests that the size and frequency of deep breaths plays 































































an important role in determining the effect in the context of underlying heterogeneous airway 
narrowing and ventilation [83].  Finally, similar to the issue with airway closure, ventilation 
heterogeneity would be expected to have important effects on aerosol deposition, limiting the 
efficacy of this form of treatment in asthma [276].
Airway Hyperresponsiveness
Airway hyperresponsiveness (AHR) is a characteristic feature of asthma, and yet the term 
encompasses multiple definitions and methods by which it is measured. Ultimately different 
definitions/measurements are likely influenced by different pathophysiologies and as such, it is 
important to understand the differences before discussing the potential underlying mechanisms. 
Woolcock et al [293] administered increasing doses of an ASM agonist to asthmatic and healthy 
participants and reported two distinct differences in the nature of the dose response curve (Figure 
14). Firstly, asthmatic participants had an increased sensitivity to response, leading to the 
leftward shift in the dose-response curve. Secondly, the dose-response curve in asthmatic 
participants was characterized by excessive bronchoconstriction, whereby there was no 
measurable response plateau. This excessive airway narrowing was equivalent to that seen in 
vitro [241]. On the other hand, a maximal response plateau was reported in healthy participants, 
in which large doses of agonist minimally reduced lung function. Therefore, the term AHR is 
used to describe the combination of the left-ward shift in the dose-response curve and the 
increase in the maximal response, whereas hypersensitivity is used to specifically denote the 
leftward shift in the dose-response curve  [242]. Hypersensitivity can be measured as a lower 
dose that causes a pre-specified response, usually a 20% fall in FEV1, and can be measured as 































































the provocative dose (PDFEV1) [51]. Similarly, the fall in FEV1 can be plotted on a linear dose 
axis in order to calculate the dose-response slope, providing a measure of AHR in all subjects, 
and not just those whose response meets the pre-specified threshold [222]. In contrast, the 
maximal response plateau, or the lack thereof, is rarely measured in patients with asthma, either 
in research or clinical settings, and it is often not considered in animal models of allergic airways 
disease. Nonetheless, it is important to remember that AHR encompasses both hypersensitivity 
and loss of the response plateau when considering potential underlying mechanisms of AHR in 
human asthma. 
Types of AHR - Direct vs. Indirect challenge
Airway hyperresponsiveness can be measured by stimuli which directly act upon effector cells 
leading to airflow obstruction (direct stimuli), or by stimuli which act upon intermediary cells 
which then act upon effector cells to cause airflow obstruction (indirect stimuli) [263] (Figure 
15). The most common direct stimuli are histamine and methacholine, a synthetic mimetic of 
acetylcholine. Histamine acts through H1 receptors on airway smooth muscle to cause 
contraction and H2 receptors to cause the release of mucous [229]. H4 receptors have recently 
been discovered on hematopoietic cells [183], although it is likely that any contribution to 
asthma pathophysiology is due to effects on inflammation rather than on acute airway 
hyperresponsiveness. Methacholine stimulates muscarinic 3 receptors on airway smooth muscle 
to cause contraction and antagonizes relaxation through muscarinic 2 receptors [85].  Both 
histamine and methacholine likely contribute to airway narrowing through vagal reflex and local 
neurally-mediated mechanisms, although the contribution to AHR is unclear [231, 274].   At 































































present the role of muscarinic 1 receptors in response to methacholine in humans is unknown, 
although they appear to contribute to airway responses in rabbits [256] and parenchymal 
responses in dogs [237].  Furthermore, the release of mucous by direct stimuli is at least in part 
mediated by the airway epithelium [145]. Interestingly, maximal airway narrowing following 
methacholine can be further increased by histamine inhalation, suggesting differences in 
mechanisms or synergistic effects of the two direct stimuli [243]. However, AHR to direct 
stimuli is not specific to asthma, and has been reported in patients with chronic obstructive 
pulmonary disease [260], cystic fibrosis ([262]) and cardiac disease [226]. 
Indirect stimuli cause the release of mediators that mimic the inflammatory airway environment 
characteristic of asthma. Indirect stimuli are therefore thought to better reflect pathophysiology 
specific to asthma [90]. Indirect challenges can be split into those which employ a single strong 
stimulus, such as exercise and eucapnic voluntary hypernoea (EVH), and those which employ 
graded stimuli, such as hypertonic saline, mannitol, adenosine-5′-monophosphate (AMP) and 
allergen [90]. The development of indirect tests of AHR was based upon the recognition that 
exercise could cause asthma exacerbations and that the drug disodium cromoglycate could 
reduce exercise induced bronchoconstriction despite no direct action on airway smooth muscle 
[5]. The high ventilation during exercise and EVH increases the volume of air that is humidified 
during passage to the lower airways, leading to the loss of respiratory water and heat. As such, 
the major determinant of the response to exercise and EVH is the intensity of ventilation 
achieved. The loss of water triggers mucosal dehydration and an increase in osmolarity of the 
liquid surface lining the airways [254]. In response to the increased osmolarity, prostaglandin D2, 
cysteinyl leukotrienes and potentially histamine are released into the airways by resident 































































structural and inflammatory cells, particularly mast cells and eosinophils [33, 91, 119]. These 
mediators then act on airway smooth muscle to cause contraction and airway narrowing. 
Exercise does not appear to recruit inflammatory cells into the airways suggesting that indirect 
tests reflect the resident inflammation environment [91]. Activation of sensory nerves may also 
contribute to exercise-induced bronchoconstriction although there is limited evidence in humans 
[111]. 
The other indirect stimuli cause bronchoconstriction at various levels of the aforementioned 
pathway. Hypertonic saline and mannitol challenges initiate bronchoconstriction by directly 
increasing the osmolarity of airway surface liquid leading to activation of mast cells and 
subsequent release of mediators [32, 167]. Similarly, AMP also likely activates mast cells to 
initiate the inflammatory cascade leading to airway smooth muscle contraction. Allergen 
challenge replicates both T-helper type-1 (innate) and type-2 (adaptive) inflammation through 
interaction with the airway epithelium and subsequent recruitment of inflammatory cells [48] as 
well as activation of mast cells, basophils and eosinophils through antigen-IgE complexes.  
The dependence of indirect AHR on the release of inflammatory mediators suggests that they 
may better reflect underlying inflammation than direct challenges. Accordingly, levels of 
exhaled nitric oxide and sputum eosinophils are more closely correlated with the severity of 
AHR measured by indirect tests than by methacholine [18, 212]. Similarly, the more rapid 
response  to inhaled corticosteroid treatment of indirect AHR compared to direct AHR suggests 
that indirect tests may better reflect underlying inflammation [66]. While AHR to mannitol has 
been reported in patients with mild-moderate COPD, the strong association with biomarkers of 































































eosinophilic airway inflammation further supports the association between indirect challenge 
AHR and underlying active inflammation [61]. There is a moderate correlation between the 
severity of AHR measured by mannitol and histamine, although there is a high discordance 
between AHR defined by direct and indirect stimuli [133, 154]. However, patients with AHR to 
both indirect and direct stimuli have the greatest risk of exacerbation following down-titration of 
inhaled corticosteroid treatment [154], again suggesting that they reflect, at least in part, different 
and additive pathophysiology. 
Airway Responsiveness as a Continuous Variable
AHR is not a binary classification but rather the extreme end of a non-normal distribution [203]. 
AHR is present in 7-20% of the general population [189, 202]. The severity of airway 
responsiveness is at least partially fluid. For example, in patients with asthma, an increase in the 
severity of AHR can occur during seasonal allergen exposure or after acute allergen challenge 
[27, 52]. Similarly, airway responsiveness can be increased in normal healthy subjects through 
the avoidance of deep inspiration, reduction in functional residual capacity, supine posture, and 
in the pathological setting of obesity. Each of these interventions provide important insight into 
the pathophysiology of AHR and therefore will be considered as an introduction to 
understanding the mechanisms of AHR in asthma.  
The Effect of Deep Inspiration Avoidance on Airway Responsiveness































































Normal tidal breathing predominantly involves breaths of relatively small volume compared to 
total lung capacity (TLC). However, these are periodically punctuated by breaths of increased 
volume, from slightly greater than normal up to full inspiratory maneuvers, referred to as deep 
inspirations (DIs) [28]. DIs of at least three times tidal volume occur every six minutes [17] and 
are due to a vagally mediated mechanoreflex which is both initiated and regulated by afferent 
input from peripheral chemoreceptors [11]. These DIs have two important effects in health: they 
protect against subsequent bronchoconstriction (bronchoprotection) and reverse existing 
bronchoconstriction (bronchodilatation) [46]. The extent of bronchodilatation is reduced in 
asthma due to both an inability to dilate airways and increased rate of re-narrowing [224]. In 
contrast, DI bronchoprotection is completely lost in asthma [234] and in subjects with AHR who 
do not have asthma [227], suggesting that the loss of DI bronchoprotection is one of the primary 
causes of AHR.
The increase in airway responsiveness in normal healthy subjects following DI avoidance was 
initially speculated to be due to the loss of large length excursions necessary for normal airway 
smooth muscle function [234]. This was based on in vitro experiments showing that the airway 
smooth muscle is highly plastic and that force-generating capacity can be acutely reduced in 
response to acute alterations in resting length [279]. This is thought to be due to structural re-
arrangement of the contractile elements of airway smooth muscle [88] or alterations in cross-
bridge dynamics [88]. However, the profound effect of length perturbations on ASM strips in 
vitro was not replicated when experiments were scaled to whole airway segments undergoing 
cyclical stretching matching normal breathing [6, 187].  This is consistent with evidence that DI 
avoidance in healthy people does not increase airway narrowing measured as respiratory system 































































resistance (118), specific airway conductance or partial expiratory flow (31). In contrast, Lutchen 
et al [160] reported that avoiding DI increases the response to methacholine as measured by 
elastance at 8Hz, as well as resistance and elastance at very low frequencies down to 0.1Hz, 
reflecting peripheral airways and lung tissue. Computational modelling suggested this was due to 
heterogeneous constriction involving airway closure or near closure. This was later confirmed by 
Chapman et al [45] who reported that DI avoidance led to increased airway closure, but not 
airway narrowing, during subsequent methacholine challenge. 
The mechanisms underlying DI bronchoprotection are currently unclear, but avoiding DI itself 
does not alter respiratory system resistance, respiratory system reactance, specific airway 
conductance, residual volume or partial expiratory flow [45, 57]. Instead, it is likely that 
avoiding DI somehow ‘primes’ the airways for an increased response once the airway smooth 
muscle is stimulated. Continuous tidal volume ventilation without Dis leads to abnormal 
surfactant structure and increased surface tension in rabbits suggesting that DI avoidance may 
disrupt normal surfactant homeostasis and predispose to airway closure [98, 252]. Indeed, 
distortion of alveolar cells by DI causes the release of pulmonary surfactant in rats [184] and if 
the release of surfactant in healthy subjects is similarly dependent upon distortion, then DI 
avoidance could result in an inadequate supply of surfactant. A role for surfactant in DI 
bronchoprotection is consistent with the finding that bronchoprotection is dramatically reduced 
when the DI is expired to residual volume (instead of to FRC) [45], since expiration to low lung 
volume causes the loss and/or deactivation of surfactant molecules [267]. Together, these 
findings lead to the speculation that DI avoidance alters peripheral airway properties, potentially 































































due to surfactant dysfunction, that then predisposes to increased airway closure and increased 
AHR.
The Effect of Lung Volume on Airway Responsiveness
The effect of lung volume on airway responsiveness has provided considerable understanding to 
the pathophysiology of AHR in asthma as well as to the link between asthma and obesity. 
Reducing end expiratory lung volume leads to increased airway responsiveness in healthy 
subjects whether done by voluntary breathing at low lung volumes, supine posture or increasing 
the external load on the chest wall [44, 63, 175]. This effect is seen as a substantial increase in 
the maximal response plateau, without any alteration in sensitivity [63]. While the mechanisms 
are not fully understood, three hypotheses predominate in the literature. Firstly, low lung volume 
breathing may allow airway smooth muscle to adapt to a shorter length thereby generating 
increased force and greater airway narrowing [214]. Indeed, reducing FRC by ~25% in sheep 
with rigid chest strapping increased the in vitro rate of stress generation in airway smooth muscle 
[171]. Secondly, a reduction in FRC would reduce the outward tethering forces exerted on the 
airways by the lung parenchyma [173]. The interdependence between the airways and 
parenchyma maintains airway caliber so that a reduction in this force would be expected to 
contribute to airway collapse, especially during airway narrowing.  Both voluntary low lung 
volume breathing [109] and chest wall strapping increase ventilation heterogeneity [44] which 
computational modelling predicts would predispose to localized and exaggerated airway closure 
upon ASM stimulation (134). Indeed, chest wall strapping leads to exaggerated airway closure 
during bronchial challenge [206]. Interestingly, the reduction in lung volume and increase in 































































ventilation heterogeneity independently contribute to the increase in airway responsiveness with 
chest wall strapping [44] suggesting that the effects of ventilation heterogeneity on AHR in 
asthma may be independent of alterations in ASM function and airway-parenchymal 
interdependence. 
In obesity, increased adiposity exerts a force on the lungs that shifts the balance between the 
inflationary and deflationary pressures [223], leading to the characteristic reduction in functional 
residual capacity (FRC) [117]. As discussed above, lung volume has long been recognized to 
regulate airway responsiveness and therefore this reduction in FRC has been widely speculated 
to underlie AHR in obese subjects. In obese asthmatics with little to no evidence of allergic 
inflammation (TH2-low), weight loss substantially improves AHR due to a reduction in 
peripheral airway closure [1, 47]. A recent computational model suggested that natural variation 
in properties of the airway would predispose certain individuals to AHR when airway-
parenchymal interdependence is reduced, therefore explaining why some, but not all, obese 
people have AHR [13]. Additionally, the reduction in FRC in obesity can be so extreme that tidal 
breathing occurs at or below closing volume [166] suggesting that obesity may increase 
ventilation heterogeneity [56]. However, in non-asthmatic subjects, airway closure appears 
confined to the basal lung zones [100] and therefore obesity may not increase ventilation 
heterogeneity in people without respiratory disease. Interestingly, BMI, but not waist 
circumference, correlates with the extent of airway closure during bronchoconstriction [211], 
suggesting that AHR due to obesity may not be caused by mechanical mechanisms. The authors 
speculated that the increased airway closure in obesity may be due to factors associated with 
subcutaneous adipose tissue,  such as surfactant dysfunction [112]. Thus, while breathing at low 































































lung volumes appears to be the primary reason obesity is linked to AHR, there are other aspects 
of obesity that likely play important roles as well.
Mechanisms of AHR 
Multiple mechanisms are implicated in the phenomenon of AHR (Figure 16).
Airway Smooth Muscle
Bronchoconstriction is due, at least in part, to contraction of the airway smooth muscle (ASM) 
leading to airway narrowing. Therefore, it is not surprising that dysfunction of the ASM has long 
been touted as the principle cause of AHR in asthma.  Dysfunctional ASM could be due to 
intrinsic abnormalities of the ASM itself or to altered properties induced by the inflammatory 
environment in which it resides. It is currently not clear whether the ASM is intrinsically 
abnormal in asthma and, if it is, what factors may contribute to a hyper-contractile state. Birth 
cohort studies suggest that lung function and increased airway responsiveness are evident as 
early as 1 month of age [257, 298]. These abnormalities are unrelated to markers of airway 
inflammation [298] and may even occur before allergen sensitization [103] consistent with the 
hypothesis that intrinsic dysfunction of ASM may contribute to AHR in asthma.  Similarly, there 
are distinct gene expression profiles between ASM from asthmatics and non-asthmatics, with the 
expression of four genes correlating with the severity of AHR [297]. The contribution of intrinsic 
abnormalities in ASM to AHR is further supported by the correlation between increased 
expression of the contractile proteins α-smooth muscle actin and desmin in ASM, and the 































































severity of AHR in patients with asthma [236]. Although studies have reported increased in vitro 
ASM forced generation in asthma [10, 22], this is not a consistent finding [49, 82]. Alternatively, 
an increase in ASM shortening velocity would lead to exaggerated airway narrowing even in the 
presence of normal force generation because a muscle that shortens (contracts) quickly would 
produce greater airway narrowing during expiration when the lung parenchyma is not opposing 
ASM shortening [238]. This is consistent with increased re-narrowing following full lung 
inflation in asthma [224]. Furthermore, in vitro experimentation has shown a link between 
shortening velocity and total amount of ASM shortening during oscillations mimicking tidal 
breathing [39]. Computational modelling suggested that this could either be due to increased rate 
of actin-myosin cross-bridge cycling or the rate of myosin light chain phosphorylation.  The rate 
of actin-myosin cross-bridge cycling is dependent upon  the activity of myosin light chain kinase 
(MLCK) and myosin light chain phosphatase (MLCP), with reports of increased expression of 
MLCK in asthma [161]. However, more recent data has questioned whether shortening velocity 
is in fact increased in asthma [49]. Similarly, normal subcellular structure of the ASM in asthma 
[247] further questions the role of intrinsic ASM dysfunction in AHR.   
The ASM need not to be intrinsically abnormal to contribute to AHR in asthma. We have already 
discussed the plasticity of the ASM in response to changes in length and there is substantial 
evidence to suggest that it is also highly adaptable to its environment within the airway wall. In 
asthma, this environment consists of numerous resident inflammatory cells and a milieu of pro-
inflammatory cytokines. The number of mast cells within the ASM correlates with the severity 
of AHR in asthma [232], which is likely mediated by the effect of mast cell mediators on ASM 
activation [93].  Proteases, such as matrix metalloproteinase-1 (MMP-1), are also increased 































































within ASM bundles of asthmatics and regulate in vitro ASM contractility [221]. Interleukin-4 
(IL-4), IL-13 and tumor necrosis factor-α (TNFα) have all been shown to increase ASM 
responsiveness in vitro [233]. These findings led Bosse et al to suggest that AHR in asthma is 
due to “a good muscle in a bad environment” [23].  This was based on a long line of evidence in 
which they showed that ASM adapted to an increase in basal tone to produce a synergistic 
increase in airway shortening in vitro [24] and increased airway responsiveness in both an animal 
model [153] and in healthy humans [77]. In contrast, considerable evidence suggests that an 
inflammatory environment may initiate a transition from a contractile ASM phenotype to a 
“synthetic” phenotype characterized by reduced contractile-associated proteins but increased 
proliferation and chemokine secretion [295]. However, it is unclear in what way and to what 
extent a synthetic ASM phenotype alters AHR in asthma. 
Airway Remodeling
Airway remodeling refers to the structural alterations of the airway wall characteristic of asthma 
due to a combination of chronic airway inflammation [285], early life exposures [191] and 
intrinsic factors. These changes include subepitheial fibrosis [286], ASM 
hypertrophy/hyperplasia, angiogenesis and changes in extracellular matrix composition [114]. 
Each of these changes likely contribute to an increase in the thickness of the airway wall in 
asthma and subsequently contribute to AHR. Airway resistance is inversely related to airway 
radius (Equation 1), so that a reduction in the diameter of the airway lumen due to airway 
remodeling would amplify the extent of airway narrowing for any given degree of ASM 
shortening [148, 181]. Additionally, an increase in the thickness of the adventitial layer or 































































infiltration of inflammation into the adventitial interstitium has the potential to uncouple the 
interaction between the airway wall and the lung parenchyma. The airway and lung parenchyma 
are structurally linked allowing the transmission of the elastic recoil force of the lung 
parenchyma to the airway to maintain airway caliber. A loss in airway-parenchymal 
interdependence would reduce the load against which the ASM shortens, allowing the ASM to 
shorten more before being balanced by parenchymal tethering. Consistent with both 
mechanisms, the degree of airway wall thickening in asthmatics with airway obstruction has 
been shown to correlate with the severity of AHR [26]. Lastly, computational modelling suggests 
that an effect of airway remodeling on the way in which the basement membrane buckles could 
reduce the load opposing airway narrowing and thus contribute to AHR [147], although whether 
this contributes to in vivo AHR in asthma remains unknown. 
Interestingly, there is a small body of evidence that airway remodeling in asthma may not 
increase AHR. On one hand, it has been suggested that airway remodeling, and the subsequent 
increase in airway stiffness, may actually oppose airway narrowing [172]. Milanese et al [176] 
reported reticular basement membrane was increased in patients with asthma and that the 
thickness was correlated with less severe AHR. Similarly, Niimi and colleagues reported that 
increased airway thickness measured by CT correlated with reduced airway hyperreactivity, 
suggesting that airway remodeling may limit excessive airway narrowing in patients with 
asthma. In yet another twist, recent evidence suggests that instead of being a cause of airway 
responsiveness, airway remodeling may actually be a consequence of airway responsiveness. In 
an elegant study, Grainge et al [86] showed that three episodes of bronchoconstriction due to 
either allergen or methacholine challenge was sufficient to induce similar levels of subepithelial 































































collagen deposition and mucous hyperplasia. These changes were not due to airway 
inflammation as there was no change in eosinophilic inflammation with methacholine challenge. 
Similarly, the effects were linked to bronchoconstriction because airway remodeling was not 
found in asthmatics who were administered albuterol to block airway narrowing. The underlying 
mechanisms are likely related to mechanotransduction in airway epithelial cells. Airway 
epithelial cells in vitro are sensitive to compressive forces equivalent to those experienced during 
bronchoconstriction and release numerous mediators linked to various features airway 
remodeling in asthma [198].
Airway-Parenchymal Interdependence
As discussed previously, the mechanical properties of the airways and lung parenchyma are 
structurally and functionally linked, known as air ay-parenchymal interdependence. The elastic 
load provided by the lung parenchyma determines airway caliber [244] and provides a load 
against which the ASM must shorten [181]. Comparison of the distribution of ventilation 
between different postures has shown that the distribution of bronchoconstriction is 
gravitationally dependent, i.e. when changing from supine to prone posture, airway closure 
‘shifted’ to the most dependent regions during bronchial challenge [95, 96]. This suggests that 
parenchymal distending forces are a strong determinant of bronchoconstriction because pleural 
pressure gradients due to gravity result in dependent lung regions that are less distended and thus 
exert less distending forces on the airways to resist airway narrowing and closure.  































































The importance of parenchymal independence on airway caliber and bronchoconstriction suggest 
that reductions in this elastic load may contribute to AHR in asthma. A reduction in the elastic 
load provided by the lung parenchyma may occur through three mechanisms. Firstly, damage to 
the alveolar attachments connecting the lung parenchyma and airways, as reported in fatal 
asthma [170], would result in a loss of transmission of the parenchymal forces opposing ASM 
shortening. Secondly, inflammation or accumulation of fluid within the adventitial interstitial 
space may impede the transmission of the elastic recoil of the lung to the airways i.e. effectively 
uncoupling the interdependence [164]. This is consistent with the loss of elastic recoil during an 
exacerbation of asthma which is normalized following resolution [292]. Thirdly, a reduction in 
the elastic properties of the lung parenchyma would directly reduce the outward force on the 
airways and may promote airway narrowing during ASM shortening. Although 
underappreciated, elastic recoil can be reduced in asthma as evidenced by mild centrilobular 
emphysema [80] and reduced lung density at total lung capacity [21].  While the loss of elastic 
recoil in asthma correlates with the extent of peripheral airway dysfunction [255], there is a lack 
of direct evidence that a reduction in loss of elastic recoil or loss of interdependence contributes 
to AHR in asthma. 
Airway Epithelial Function
The airway epithelium is the first barrier for inhaled spasmogens and therefore any damage to 
the integrity of the epithelium would likely allow greater access to the ASM and exaggerate 
contraction.  Indeed, mechanical removal of the airway epithelium in canine bronchial segments 
leads to increased sensitivity that is then comparable to sensitivity when the agonist is applied on 































































the adventitial surface [179]. Similarly, administration of cationic proteins to the airways of mice 
leads to damage to the airway epithelium [259] and increased airway sensitivity due to 
exaggerated ASM shortening [16]. Interestingly, cationic protein did not change the maximal 
response plateau [16]. In patients with asthma the severity of AHR correlates with increased 
epithelial damage measured quantitatively by biopsy [115] and reflected by the concentration of 
epithelial cells in sputum [91]. Furthermore, the airway epithelium is not merely a barrier but 
actively impacts its environment through secretion of multiple mediators. For example, release of 
epithelial-derived relaxing factor maintains relaxation of ASM [264]. Therefore it is not 
surprising that damage to the epithelium decreases its ability to reduce ASM activation [55]. 
Furthermore, epithelial cells may themselves contribute to airway narrowing since it has been 
shown that rupture of small airway epithelial cells in vitro induce intracellular [Ca2+] waves and 
subsequent contraction in neighboring ASM [299]. Similarly, epithelial cells exposed to 
mechanical compression equivalent to bronchoconstriction cause an endothelin-1 mediated 
increase in ASM contraction [149]. Lastly, damage to the airway epithelium is associated with an 
increase in inflammatory mediators, such as IL-33, which may contribute to AHR through 
exaggerated (eosinophilic) airway inflammation [89]. All the above mechanisms are likely 
especially relevant to the development of occupational asthma following inhalation of noxious 
molecules.
Neural Control
The airways are richly innervated by both the sympathetic and parasympathetic nervous system, 
so it is no surprise that neural input regulates airway tone and indeed is implicated in AHR. 































































There is strong evidence that cholinergic activity is increased in asthma and implicated in airway 
narrowing, as is seen clinically by the significant bronchodilating effect of anticholinergic 
aerosols such as ipratropium.  Anticholinergics also markedly reduced AHR to a wide variety of 
stimuli [42].  In addition, nedocromil inhibits sensory nerve activation and prevents AHR to 
exercise and other irritants [50], implicating the non-adrenergic, non-cholinergic nervous system 
in the pathogenesis of AHR in asthma.
Heat and Water Loss 
The main stimulus involved in AHR to exercise or hyperpnea is the heat and water lost during 
periods of high minute ventilation.  The extensive airway tree serves to warm and humidify the 
inhaled air to body temperature and humidity by the time the air has reached the alveoli.  At high 
levels of ventilation air that is not fully conditioned may penetrate deep into the airway tree and 
serve as the stimulus bronchospasm.  The primary mechanism is thought to be due to drying of 
the airway lining fluid, leading to an increase in local ion concentration and hence osmolarity, 
which serves to stimulate epithelial cells, mast cells, eosinophils and sensory nerve cells that line 
the airway to release mediators [139]. The net effect of this release is bronchospasm, caused 
mainly by release of cysteinyl leukotrienes, PGD2 and neurokinins.  The response may be 
modulated by the inspired air temperature, which if cool may cause bronchoconstriction more 
rapidly.  Asthmatics with EIB appear to have a higher density of mast cells within their epithelial 
layer [146].  Damage to the normal biological function of the airway epithelium may compound 
EIB by interfering with normal re-humidification and allowing inhaled irritants easier access to 
underlying inflammatory cells.
































































Recently it has been speculated that increased baseline ventilation heterogeneity may be a 
mechanism which could lead to AHR in asthma.  At the anatomic level, it seems apparent that 
heterogeneity of inflammation throughout the lung, and of airway wall dimensions and ASM 
would contribute to AHR [200], and enhance AHR [81], as shown by computational modeling.  
However, ventilation heterogeneity seems to be important in determining AHR independent of 
inflammation [65].   Venegas et al (134) used positron emission tomography (PET) to show that 
during induced bronchoconstriction asthmatic subjects develop areas of severely under-
ventilated lung. However, these ventilation defects were not totally devoid of ventilation, but 
rather included airways which contained normal levels of ventilation, suggesting that these 
ventilation defects were not due to closure of large airways alone. The authors developed a 
highly advanced lung model that takes account of the effects of the tethering forces of the lung 
parenchyma in which the airways are embedded, the intra- and extra-luminal pressures and the 
smooth muscle forces (134). The model predicts that uniform ASM contraction with the addition 
of small, random heterogeneities in airway caliber would lead to the abrupt development of 
airway closure when ASM contraction reaches a critical level of instability. The increase in 
airway narrowing and decrease in the volume of local alveoli results in the reduction in 
parenchymal tethering forces, initiating a short-range feedback mechanism whereby airway 
closure propagates up and down the airway tree. This development of large clusters of airway 
closure was consistent with the PET images and their model suggested that they would occur 
even with small levels of ASM stimulation. An increase in baseline ventilation heterogeneity 































































may provide sufficient airway instability to initiate this positive feedback mechanism. Increased 
baseline ventilation heterogeneity is not necessarily specific to one disease process, but rather 
could be induced by any process that leads to non-uniform airway caliber, such as airway 
remodeling, intraluminal exudate or reductions in elastic recoil. This theory therefore includes 
and combines the effects of the many abnormalities of asthma that may result in an uneven 
distribution of airway calibers throughout the airway, potentially explaining their role in both the 
increased sensitivity and excessive bronchoconstriction which are characteristic of AHR.  
Parenchymal Lung Mechanics in Asthma
One of the most important means to detect changes in the functional properties of the lung 
parenchyma is by measurement of the pressure-volume (PV) curve.  Typically the PV curve in 
stable asthma is normal or shifted upward, indicating normal or increased lung volumes but 
normal elastic recoil [53, 102].  During acute exacerbations of asthma, the PV curve may shift 
upward and to the left, indicating loss of elastic recoil [292]. The loss of recoil has been 
postulated to be due to stress-relaxation of the elastic elements in the lung parenchyma [102].  In 
most cases following the exacerbation, lung compliance appears to return to normal.  There are 
also some asthmatics who have PV curves persistently shifted up and to the left, which suggests 
a chronic loss of recoil [79, 80].  The etiology of this loss of recoil is unknown, but there may be 
evidence of microscopic emphysema in such patients [80].  In some cases during acute 
exacerbation, the PV curve may shift down and to the right, with the apparent loss of lung 
volume and increased recoil likely due to  airway closure [292], possibly from surfactant 
dysfunction.   Surfactant is an important component of the alveolar structure, as it exists within 































































the alveolar lining fluid and serves to regulate surface tension.  Surfactant function is disrupted 
by any type of protein presence, and since inflammation involves the elaboration of protein, it is 
not surprising that surfactant function may be compromised in asthma [99].  This would tend to 
reduce lung compliance and make it easier for narrowed airways to close, a mechanism that is 
thought to potentially contribute to the increased propensity for airway closure in asthma.  
Interestingly, ASM tone can increase parenchymal stiffness, presumably from transmission of 
retraction forces into the surrounding lung parenchyma [180].  This may the cause of so-called 
“reversible restrictive lung disease”, in which an apparently stiff lung based on a rightward and 
downward shift of the PV curve can be brought back to the normal position following albuterol.  
One case report of this implicated increased ASM tone around the alveolar duct region, that 
resulted in an increase in overall lung stiffness [123]. Thus, there appear to be competing factors 
affecting the mechanical properties of the lung parenchyma, those that increase elastic recoil, 
such as surfactant dysfunction, and perhaps involving increased ASM tone in the airways or lung 
parenchyma, and those that decrease elastic recoil, such as from chronically elevated lung 
volumes and perhaps microscopic emphysema.  
Relationship of Lung Mechanics to the Clinical Manifestations of Asthma
Many of the consequences of altered lung mechanics and how they relate to the clinical 
manifestations of asthma have been discussed. For example, airway narrowing leads not only to 
increased work of breathing from elevated airway resistance, but also increased work of 
breathing due to air trapping and hyperinflation, markedly affecting the symptom of dyspnea 
[155].  Heterogeneity of airway narrowing and ventilation leads to increased propensity for AHR 































































[44, 65, 67, 70, 94, 156].  Ventilation heterogeneity has also been linked to asthma control [68, 
69]. Loss of lung recoil, whether anatomic or functional, may predispose to sudden, acute 
worsening or even near fatal asthma [79].  Recently, Antonelli and colleagues examined the 
mechanical correlates of dyspnea in asthma by carefully comparing symptoms to alterations in 
lung mechanics measured by the FOT in response to methacholine [7].  Low levels of 
bronchoconstriction caused dyspnea that were associated with dyspnea related to airway 
narrowing and loss of bronchodilation after DI, perhaps due to more central airway narrowing, 
whereas higher levels of bronchoconstriction were associated with dyspnea related to ventilation 
heterogeneity and loss of lung volume from airway closure, perhaps due to more peripheral 
airway narrowing [7].  
Thus, it is clearly apparent that the symptoms and clinical manifestations of asthma extend well 
beyond the simple effects of airway narrowing and resulting increase in airway resistance 
(Figure 17).  We are just now appreciating the importance of altered lung mechanics beyond 
airflow limitation in asthma, and may soon realize the clinical utility in measuring respiratory 
system impedance, ventilation heterogeneity, and other aspects of altered lung mechanics that 
may help us better care for our patients with asthma. 
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Table 1 – Consequences of Airway Narrowing
 Wheezing
 Expiratory flow limitation




































































Figure 1 – Illustration of major inflammatory mechanisms involved in asthma pathogenesis. The 
healthy airway is depicted at the top, with airways smooth muscle surrounding the airway 
epithelium sitting on the reticular basement membrane.  Moving counterclockwise, eosinophilic 
asthma is seen by increased eosinophilic inflammation driven by allergen stimulation resulting in 
increased eosinophilic and mast cell activation.  Next is seen non-allergic eosinophilic 
inflammation driven by pollutants and microbes also resulting in increased eosinophilic 
inflammation activation.  In the lower right section is seen Type 1 and Type 17 neutrophilic 
inflammation, driven by pollutants, microbes and oxidative stress, resulting in increased 
neutrophil activation.  Non-eosinophilic asthma may also be paucigranular (top right), with few 
inflammatory cells, or mixed granulocytic, with both eosinophilic and neutrophilic inflammation 
(bottom).  From [195], with permission.
Figure 2 – Illustration of key factors determining airway narrowing.  Airway caliber is regulated 
by surrounding airway smooth muscle force balanced against parenchymal tethering. Other 
factors that modulate airway caliber include the thickness of the airway wall due to 
inflammation, edema and remodeling, mucosal folding, and the elastic properties of the airway 
wall.  From [97], with permission.
Figure 3 – Illustration of effects of deep inhalation (DI) on airway size based on the concept of 
relative hysteresis of airway and lung parenchyma.   A)  Airway and lung pressure vs. volume 
curves showing equal hysteresis of airway and lung, as seen by the area within the P-V curves.  































































In this circumstance, a deep inhalation results in no change in airway caliber, as seen by the 
symmetrical balance of Pressure for a given Volume on the left, and the equal diameters of the 
airways on the right.  B) PV curves showing airway greater than parenchymal hysteresis, which 
results in a bronchodilator response to deep inhalation, as seen by the greater dilator force after 
inhalation. C)  PV curves showing parenchymal greater than airway hysteresis, which results in a 
bronchoconstrictor response to deep inhalation, as seen by the greater constrictor force after 
inhalation.  From [207], with permission.
Figure 4 – Diagram illustrating fluctuations in peak flow over time.  This recording shows 
fluctuating peak flow measured twice daily over 150 days.  The statistical pattern of fluctuation 
is similar at different time scales, as seen by the inset showing magnification of a shorter time 
period, illustrating the fractal properties of this time series.  From [75], with permission.
Figure 5 - Single Breath Nitrogen Washout trace from a healthy 21 year old male without 
respiratory disease. Participant inhaled 100% O2 from residual volume (RV) to total lung 
capacity (TLC) and then expired from TLC to RV. The expiratory nitrogen trace is comprised of 
four distinct phases: phase I (dead space), phase II (bronchial ventilation), phase III (alveolar 
ventilation) and phase IV (sudden increase indicating onset of airway closure). Closing volume 
(CV, blue bar) is the expired volume between the onset phase IV and RV. Closing capacity (CC) 
is calculated as CV + RV. The slope of phase III is plotted between 25% and 75% of vital 
capacity (orange dashed line). Note the unconventional x-axis in which volume been plotted 
based on total lung capacity measured by body plethysmography to show CC and RV.  































































Figure 6 – Illustration of effects of homogeneous vs. heterogeneous airway constriction on 
Resistance and Elastance measured by the forced oscillation technique.   Left, resistance is 
plotted against frequency and compared between the healthy state and different states of airway 
constriction. Under conditions of homogeneous constriction, there is relatively uniform elevation 
of R across the frequency range.  Under conditions of heterogeneous constriction, there is 
marked frequency dependence, with R at lower frequencies being markedly elevated.  Right, 
effects of different airway constriction patterns on elastance (E) relative to the healthy state.    
Homogeneous constriction causes most of the oscillatory input signal to be shunted into the 
central airways, resulting in a uniform increase of E with frequency.  Heterogeneous airway 
constriction results in a marked rise in E with a jump in E at breathing frequency reflecting 
airway closure.   From [156], with permission.
Figure 7- De-recruitment measured by forced oscillation technique in a 21 year old healthy male 
without respiratory disease. The participant performed a slow vital capacity during which 
respiratory system reactance (Xrs) was continuously measured and the points of de-recruitment 
(DR1 = diamond, DR2 = circle) calculated as previously described (Nilsen et al, JAP, 2019). 
Note that functional residual capacity (FRC) occurs above both de-recruitment points and that 
closing capacity (CC) measured from the Single Breath Nitrogen Washout test occurs at 
approximately the same volume as DR2. 
Figure 8 – Imaging of heterogeneous ventilation by hyperpolarized helium (3He)-MRI.   Shown 
in this example are the ventilation images obtained from a healthy subject (A), compared to 3 
different subjects with mild (B), moderate (C) and severe (D) asthma.  Notice the increasing 































































number of ventilation defects (white arrows), reflecting functional airway closure, as asthma 
becomes more severe.  From [225], with permission.
Figure 9 – Imaging of heterogeneous ventilation by ventilation SPECT/CT.  Shown are the 
images from one subject before (left) and after (right) methacholine.  Not only are there larger 
and new poorly ventilated or non-ventilated spaces (black), but the ventilation has become more 
heterogeneous within the ventilated airspaces, as seen by the color-coding of ventilation and the 
histogram distribution of ventilation below the images.  From [70], with permission.
Figure 10 - Nitrogen trace from a Multiple Breath Nitrogen Washout test. The participant was 
instructed to take tidal volume breaths of approximately 1 liter until end-expiratory nitrogen 
concentration had fallen by 1/40th of the initial concentration (~2.5%).  Lung Clearance Index 
(LCI) is calculated as the lung turnover (cumulative expired volume/functional residual capacity) 
at this point. Insets show the phase III slope normalized by the mean expiratory nitrogen 
concentration for the 1st and 25th breaths, respectively.
Figure 11 - Derivation of two parameters of ventilation heterogeneity from the multiple breath 
nitrogen washout test. The slope of the plot between lung turnovers 1.5 and 6 reflects ventilation 
heterogeneity occurring in airways where gas transport is dependent upon convection. This slope 
is termed Scond as it is felt to represent ventilation at the level of the peripheral conducting 
airways.  The (normalized) phase III slope of the first breath (minus the contribution of Scond 
i.e. Scond x lung turnover at first breath) reflects ventilation heterogeneity at the interface 
between convection and diffusion gas transport, known as the diffusion front. This is felt to 































































represent the heterogeneity of the ventilation at the entrance to the acinar region, and is termed 
Sacin.  Data are shown from a 34 year old male with normal lung function ( ) and a 45 year old 
female with asthma ( ).  
Figure 12 – Illustration of anatomic areas of involvement in determining conduction-dependent 
and diffusive-conductive dependent ventilation.  While not meant to precisely indicate anatomic 
location, Scond is seen to arise in more proximal conducting airways, and Sacin is seen to arise 
in more distal airways at the junction between conductive and acinar ventilation.   From [271], 
with permission.
Figure 13 – Parallel and Serial Airway Interdependence Leading to Heterogeneous Ventilation.  
This illustration depicts a symmetrically bifurcating airway tree under uniform ASM constriction 
(red lightning bolts).  On the left is illustrated the consequences of parallel interdependence of 
airways on ventilation.  One airway has a slightly thicker airway wall than the other (red 
area).  Accordingly, during ASM constriction, airflow is reduced more to this airway than its 
daughter branching airway (dashed arrow).  The reduced airflow leads to reduced distal 
ventilation, and hence reduced expansion of the surrounding lung parenchyma.  This leads to 
reduced tethering forces on the embedded airway, allowing less stretch of the ASM, and 
therefore enhancing its constriction. This pattern results in a vicious cycle (curving arrows) 
culminating in widespread loss of ventilation to the parenchyma fed by that 
airway (“catastrophic airway collapse”). This is seen as a ventilation defect seen on imaging 
(Vdef).  Meanwhile, under conditions of conserved total minute ventilation, airflow is diverted 
away from the thickened airway into the daughter airway without airway wall thickening (thicker 































































arrow) increasing ventilation to the parenchyma served by that airway. This results in increased 
expansion of that parenchymal area with consequent increased tethering forces and increased 
tidal ASM stretch and dilation of the airway.  This process also cycles until a dynamic 
equilibrium of airway size and parenchymal expansion is reached.  
 
On the right is shown the consequences of serial interdependence of airways.  Transmural 
pressure across the airway is greater for central than peripheral airways during tidal breathing, 
such that under conditions of uniform ASM constriction, central airways are stretched more 
during tidal breathing than peripheral airways, resulting in a net greater narrowing of peripheral 
airways than central airways. The end result may once again be ventilation defects seen on 
imaging.  Adapted from [289], with permission.
Figure 14 – Illustration of airways hyperresponsiveness based on dose-response curves relating 
FEV1 to methacholine concentration.  The normal subject is characterized by 
bronchoconstriction to methacholine only at high doses, with a 20% fall in FEV1 occurring 
above 64 mg/ml and a plateau at higher levels.  The mild asthmatic is hyperresponsive to 
methacholine, as seen by the upward (increased response) and leftward (increased sensitivity) 
shift of the dose-response curve, resulting in a PC20 of 4 mg/ml, and no clear plateau.  The 
severe asthmatic has even more hyperresponsiveness, with a further shift up and to the left of the 
dose response curve resulting in a PC20 of 1 mg/ml and no plateau.   From [190], with 
permission.































































Figure 15 – Pathways involved in direct and indirect airways hyperresponsiveness.  On the left is 
depicted the events occurring in exercise or hyperpnea-induced bronchoconstriction, where 
respiratory water loss results in increased osmolarity of the airway surface liquid, which 
stimulates mediator release from mast cells and eosinophils, resulting in airway smooth muscle 
(ASM) constriction. On the right are the events involved in allergen challenge, where the 
allergen-IgE complex activates cellular inflammation and subsequent ASM constriction.  Both 
exercise/hyperpnea and allergen challenges (or hypertonic saline, mannitol or adenosine 
monophosphate) are considered indirect challenges because they stimulate ASM constriction 
indirectly via proximal mediators and events. This is in contrast to methacholine or histamine 
challenge which result in direct stimulation of ASM.  From [190], with permission.
Figure 16 – Mechanisms involved in airways hyperresponsiveness.  Multiple factors govern 
airway responsiveness, including ASM contractility, mechanical load on ASM (opposing or 
enhancing ASM constriction), geometry of the airway (amplifying ASM constriction), and 
delivery of the agonist (enhancing the sensitivity to agonist). In addition, not shown directly, 
heterogeneity of airway constriction throughout the lung also contributes to responsiveness.  
From [12], with permission.
Figure 17 – Summary illustration of influence of altered lung mechanics on clinical 
manifestations of asthma.  This highly schematic summary reminds us that many aspects of lung 
mechanics are involved in the clinical manifestations of asthma as measured by asthma severity 
and asthma control. These include increased airway resistance due to multiple factors governing 
airway caliber, including airway smooth muscle tone, airway wall thickness and stiffness, 































































surrounding lung elastic recoil and airway-parenchymal interdependence.  Subsequent effects 
include airflow limitation, gas trapping, ventilation heterogeneity, and airway 
hyperresponsiveness.  Adapted from [192], with permission.

































































Teaching Points:  Multiple inflammatory pathways are implicated in the pathogenesis of asthma, 
as illustrated by this summary figure. The healthy airway is depicted at the top, with airways 
smooth muscle surrounding the airway epithelium sitting on the reticular basement membrane.  
Moving counterclockwise, eosinophilic asthma is seen by increased eosinophilic inflammation 
driven by allergen stimulation resulting in increased eosinophilic activation by IL4, 5, and 13, 
and mast cell activation by IgE via TH2 cells.  Next is seen non-allergic eosinophilic 
inflammation driven by pollutants and microbes resulting in increased eosinophilic inflammation 
activation by IL5 via ILC2 cells driven by IL33, TSLP and PGD2.  In the lower right section is 
seen Type 1 and Type 17 neutrophilic inflammation, driven by pollutants, microbes and 
oxidative stress, resulting in increased neutrophil activation by CXCL8 via macrophage and TH1 
and TH17 cells.  Non-eosinophilic asthma may also be paucigranular (top right), with few 
inflammatory cells, or mixed granulocytic, with both eosinophilic and neutrophilic inflammation 
(bottom).  From [195], with permission.
Figure 2
Teaching Points:  Multiple factors determine airway narrowing, as shown in this diagram.  
Airway caliber is regulated by surrounding airway smooth muscle force balanced against 
parenchymal tethering. Other factors that modulate airway caliber include the thickness of the 
airway wall due to inflammation, edema and remodeling, mucosal folding, and the elastic 
properties of the airway wall.  From [97], with permission.
































































Teaching Points:  The effects of a deep inhalation (DI) can be described by considering the 
relative hysteresis of airway and lung parenchyma.   Hysteresis is reflected in the area inscribed 
by the inspiratory and expiratory pressure (P) vs. volume (V) curves.  An increase in airway 
hysteresis means that a dilated airway retains a more relaxed state after inspiration.  An increase 
in parenchymal hysteresis means that after the lung parenchyma is stretched, it exerts less of a 
recoil pressure on embedded airways.  Accordingly, 3 states are shown.  In A), airway and 
parenchymal hysteresis are equal, so that a deep inhalation results in no change in airway caliber, 
as seen by the symmetrical balance of Pressure for a given Volume on the left, and the equal 
diameters of the airways on the right.  In B), PV curves showing airway greater than 
parenchymal hysteresis, which results in a bronchodilator response to deep inhalation, as seen by 
the greater dilator force after inhalation. C)  PV curves showing parenchymal greater than airway 
hysteresis, which results in a bronchoconstrictor response to deep inhalation, as seen by the 
greater constrictor force after inhalation.  From [207], with permission.
Figure 4 
Teaching Points:  Peak flow can vary greatly over time, as shown in this example recording of 
peak flow measured twice daily over 150 days.  The statistical pattern of fluctuation is similar at 
different time scales, as seen by the inset showing magnification of a shorter time period, 
illustrating the fractal properties of this time series, meaning that the pattern fluctuates with a 
similar pattern no matter the amount of time considered (e.g., minutes to hours to days).  From 
[75], with permission.
































































Teaching Points:  This tracing of a Single Breath Nitrogen Washout from a healthy 21 year old 
male without respiratory disease illustrates multiple points about gas distribution within the lung. 
The participant has inhaled 100% O2 from residual volume (RV) to total lung capacity (TLC) 
and then expired from TLC to RV. The expiratory nitrogen trace is comprised of four distinct 
phases: phase I (dead space gas containing pure oxygen from the inhalation), phase II (bronchial 
ventilation showing sudden rise in nitrogen coming from conducting airways that received little 
oxygen during inhalation), phase III (alveolar ventilation representing the net sum of nitrogen 
concentrations coming from all the alveolar spaces as the lung progressively empties) and phase 
IV (sudden increase in nitrogen concentration indicating onset of airway closure where only the 
most distal alveoli empty their nitrogen content). Closing volume (CV, blue bar) is the expired 
volume between the onset phase IV and RV. Closing capacity (CC) is calculated as CV + RV. 
The slope of phase III is plotted between 25% and 75% of vital capacity (orange dashed line) and 
reflects the eveneness of ventilation; the flatter the slope, the more homogeneous is overall 
ventiation. Note the unconventional x-axis in which volume been plotted based on total lung 
capacity measured by body plethysmography to show CC and RV.  
Figure 6 
Teaching Points:  This figure illustrates the effects of homogeneous vs. heterogeneous airway 
constriction on Resistance and Elastance measured by the forced oscillation technique.   Left, 
resistance is plotted against frequency and compared between the healthy state and different 
states of airway constriction. Under conditions of homogeneous constriction, there is relatively 
uniform elevation of R across the frequency range.  Under conditions of heterogeneous 































































constriction, there is marked frequency dependence, with R at lower frequencies being markedly 
elevated.  Right, effects of different airway constriction patterns on elastance (E) relative to the 
healthy state.    Homogeneous constriction causes most of the oscillatory input signal to be 
shunted into the central airways because it cannot penetrate the homogeneously constricted 
peripheral airways, resulting in a uniform increase of E, which rises with frequency because 
higher frequency flow signals can penetrate less and less into the periphery.  Heterogeneous 
airway constriction results in a marked rise in E with a jump in E at low frequencies around the 
breathing frequency reflecting airway closure. Note that the rise in E in both circumstances does 
not necessarily reflect a pure stiffening of the lung parenchyma, but rather is related to the 
pattern and degree of rise in R; in this way, it is a functional increase in lung stiffness, rather than 
related to stiffer structural elements.  From [156], with permission.
Figure 7
Teaching Points:  This tracing illustrates the process of lung de-recruitment measured by forced 
oscillation technique in a 21 year old healthy male without respiratory disease. The participant 
performed a slow vital capacity during which respiratory system reactance (Xrs) was 
continuously measured and the points of de-recruitment (DR1 = diamond, DR2 = circle) 
calculated as previously described[185]. Essentially, as the lung empties, and de-recruitment 
results in airway closure, there are abrupt increases in E (similar to as described in Figure 6) that 
are seen by abrupt more negative measures of Xrs.  Note that functional residual capacity (FRC) 
occurs above both de-recruitment points and that closing capacity (CC) measured from the 
Single Breath Nitrogen Washout test occurs at approximately the same volume as DR2. 
































































Teaching Points:  This is an example of imaging of heterogeneous ventilation by hyperpolarized 
helium MRI.   Shown in this example are the ventilation images obtained from a healthy subject 
(A), compared to 3 different subjects with mild (B), moderate (C) and severe (D) asthma.  Notice 
the increasing number of ventilation defects (white arrows), reflecting functional airway closure, 
as asthma becomes more severe.  From [225], with permission.
Figure 9 
Teaching Points:  This is an example of imaging of heterogeneous ventilation by ventilation 
SPECT/CT.  Shown are the images from one subject before (left) and after (right) methacholine.  
Not only are there larger and new poorly ventilated or non-ventilated spaces (black), but the 
ventilation has become more heterogeneous within the ventilated airspaces, as seen by the color-
coding of ventilation and the histogram distribution of ventilation below the images.  From [70], 
with permission.
Figure 10 
Teaching Points:  This figure illustrates the nitrogen trace from a Multiple Breath Nitrogen 
Washout test. The participant was instructed to take tidal volume breaths of approximately 1 liter 
until end-expiratory nitrogen concentration had fallen by 1/40th of the initial concentration 
(~2.5%).  A measure of ventilation heterogeneity, the Lung Clearance Index (LCI) is calculated 
as the lung turnover (cumulative expired volume/functional residual capacity) at this point, 
meaning, how many FRC-sized volumes did it take to washout the nitrogen to this pre-defined 
level. Insets show the phase III slope normalized by the mean expiratory nitrogen concentration 































































for the 1st and 25th breaths, respectively, which is done so that the slopes at each point may be 
compared to each other.
Figure 11
Teaching Points:  This tracing illustrates the derivation of two parameters of ventilation 
heterogeneity from the Multiple Breath Nitrogen Washout test. The slope of the plot between 
lung turnovers 1.5 and 6 reflects ventilation heterogeneity occurring in airways where gas 
transport is dependent upon convection. This slope is termed Scond as it is felt to represent 
ventilation at the level of the peripheral conducting airways.  The (normalized) phase III slope of 
the first breath (minus the contribution of Scond; i.e., Scond x lung turnover at first breath) 
reflects ventilation heterogeneity at the interface between convection and diffusion gas transport, 
known as the diffusion front. This is felt to represent the heterogeneity of the ventilation at the 
entrance to the acinar region, and is termed Sacin.  Data are shown from a 34 year old male with 
normal lung function ( ) and a 45 year old female with asthma ( ).  The data from the 
asthmatic person reveals higher Scond and Sacin, indicating more ventilation heterogeneity in 
both regions, which is associated with asthma.
Figure 12
Teaching Points:  This is a conceptual illustration of the anatomic areas of involvement in 
determining conduction-dependent and diffusive-conductive dependent ventilation.  While not 
meant to precisely indicate anatomic location, Scond is seen to arise in more proximal 
conducting airways, and Sacin is seen to arise in more distal airways at the junction between 
conductive and acinar ventilation.  From [271], with permission.
































































Teaching Points:  This illustration is a conceptualized model of how parallel and serial airway 
interdependence leads to heterogeneous ventilation.  Shown is a symmetrically bifurcating 
airway tree under uniform ASM constriction (red lightning bolts).  On the left is illustrated the 
consequences of parallel interdependence of airways on ventilation.  One airway has a slightly 
thicker airway wall than the other (red area),which may be related to airway inflammation, or 
remodeling.  Accordingly, during ASM constriction, airflow is reduced more to this airway than 
its daughter branching airway (dashed arrow).  The reduced airflow leads to reduced distal 
ventilation, and hence reduced expansion of the surrounding lung parenchyma.  This leads to 
reduced tethering forces on the embedded airway, allowing less stretch of the ASM, and 
therefore enhancing its constriction. This pattern results in a vicious cycle (curving arrows) 
culminating in widespread loss of ventilation to the parenchyma fed by that 
airway (“catastrophic airway collapse”). This is seen as a ventilation defect seen on imaging 
(Vdef).  Meanwhile, under conditions of conserved total minute ventilation, airflow is diverted 
away from the main airway into the daughter airway (slightly thick arrow) without airway 
wall thickening increasing ventilation to the parenchyma served by that airway. This results in 
increased expansion of that parenchymal area with consequent increased tethering forces and 
increased tidal ASM stretch and dilation of the airway.  This process also cycles until a dynamic 
equilibrium of airway size and parenchymal expansion is reached. 
 
On the right is shown the consequences of serial interdependence of airways.  Transmural 
pressure across the airway is greater for central than peripheral airways during tidal breathing, 































































such that under conditions of uniform ASM constriction, central airways are stretched more 
during tidal breathing than peripheral airways, resulting in a net greater narrowing of peripheral 
airways than central airways. The end result may once again be ventilation defects seen on 
imaging.  Adapted from [289], with permission.
Figure 14
Teaching Points:  This figure illustrates airways hyperresponsiveness based on dose-response 
curves relating FEV1 to methacholine concentration.  The normal subject is characterized by 
bronchoconstriction to methacholine only at high doses, with a 20% fall in FEV1 occurring 
above 64 mg/ml and a plateau at higher levels.  The mild asthmatic is hyperresponsive to 
methacholine, as seen by the upward (increased response) and leftward (increased sensitivity) 
shift of the dose-response curve, resulting in a PC20 of 4 mg/ml, and no clear plateau.  The 
severe asthmatic has even more hyperresponsiveness, with a further shift up and to the left of the 
dose response curve resulting in a PC20 of 1 mg/ml and no plateau.  From [190], with 
permission.
Figure 15
Teaching Points:  This figure illustrates pathways involved in direct and indirect airways 
hyperresponsiveness.  On the left is depicted the events occurring in exercise or hyperpnea-
induced bronchoconstriction, where respiratory water loss results in increased osmolarity of the 
airway surface liquid, which stimulates mediator release from mast cells and eosinophils, 
resulting in airway smooth muscle (ASM) constriction. On the right are the events involved in 
allergen challenge, where the allergen-IgE complex activates cellular inflammation and 































































subsequent ASM constriction.  Both exercise/hyperpnea and allergen challenges (or hypertonic 
saline, mannitol or adenosine monophosphate) are considered indirect challenges because they 
stimulate ASM constriction indirectly via proximal mediators and events. This is in contrast to 
methacholine or histamine challenge which result in direct stimulation of ASM.  From [190], 
with permission.
Figure 16
Teaching Points:  This figure illustrates mechanisms involved in airways hyperresponsiveness.  
Multiple factors govern airway responsiveness, including ASM contractility, mechanical load on 
ASM (opposing or enhancing ASM constriction), geometry of the airway (amplifying ASM 
constriction), and delivery of the agonist (enhancing the sensitivity to agonist). In addition, not 
shown directly, heterogeneity of airway constriction throughout the lung also contributes to 
responsiveness.  From [12], with permission.
Figure 17
Teaching Points:  This highly schematic summary reminds us that many aspects of lung 
mechanics are involved in the clinical manifestations of asthma as measured by asthma severity 
and asthma control. These include increased airway resistance due to multiple factors governing 
airway caliber, including airway smooth muscle tone, airway wall thickness and stiffness, 
surrounding lung elastic recoil and airway-parenchymal interdependence.  Subsequent effects 
include airflow limitation, gas trapping, ventilation heterogeneity, and airway 
hyperresponsiveness.  Adapted from [192], with permission.
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